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ABSTRACT
Equine infectious anemia virus (EIAV) is the causative agent o f a
persistent disease in horses. The long terminal repeat (LTR) region of EIAV
contains the enhancer and promoter elements necessary for transcription of the
proviral genome. The LTR is also prone to a high degree of sequence variability
between different virus isolates. Sequence alignments of LTR variants from both
tissue culture-adapted strains of the virus as well as sequential horse isolates
showed a high degree of sequence variability between variants. Sequence
variability was further localized to a hypervariable region approximately 60 bp
upstream of the TATA box. This region contained insertions resulting in the
duplication of flanking sequences and the putative m-elements they contain.
Transient gene expression analysis of the LTR variants in three different cell lines
showed that the promoter activities of the LTR variants were different and that
these differences were cell line dependent. Further analysis using deletion
mutants indicated that the hypervariable and flanking regions contained several
cw-elements important for promoter activity and that duplication of these elements
increased activity under basal conditions. Analysis of infected horse tissue DNA
using competitive PCR analysis did not indicate a high degree of sequence
divergence localized to the LTR. Therefore, LTR heterogeneity may not be
required for the onset of acute disease. To assess the impact of LTR variability
on viral replication kinetics and cytopathogenicity, an infectious EIAV molecular
clone was created in which the cognate LTR region was replaced with the
corresponding region of a virus stock which demonstrates accelerated
cytopathogenic effects. The study showed that the LTR increased replication
capacity but did not influence cytopathogenicity.
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CHAPTER 1
LITERATURE REVIEW
Retroviruses
The retrovirus family of viruses is arguably the most studied group of
pathogens in human history. Initially identified in the early 1900s as filterable
agents associated with diseases in animals, retroviruses were not linked to any
human diseases until almost eighty years later with the discovery of the Human Tcell leukemia virus (HTLV), and Human immunodeficiency virus (HIV) (WongStaal, 1991).
Structure
Retroviruses are enveloped RNA viruses with a virion size of approximately
100 nm and a conical nucleocapsid (Fig. 1A). The envelope is derived from the
plasma membrane of the host. Imbedded within it are viral glycoproteins, the
products of the env gene, that form knob-like structures on the exterior of the virion
and are essential for the recognition, attachment, and penetration of the virus into
the host cell. The interior of the virion is dominated by the viral capsid. This
structure is formed from the multiple protein products of the gag gene. In addition
to the capsid, the interior of the virion contains several enzymatic activities required
for retrovirus replication. Such as the reverse transcriptase, ribonuclease H (RNase
H), and integrase enzymes encoded by the pol gene. Virion cores also contain host
tRNA which functions as a primer during the reverse transcription of the viral
genomic RNA and, in some cases, auxiliary proteins such as the viral infectivity
factor (Vif) of HIV. Associated with the nucleocapsid is the positive strand, diploid
RNA genome. These identical strands of RNA, from 7 to 10 kb in length, possess a
7mG cap at their 5' ends and are poly-adenylated like host mRNA.

1
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Figure 1. Retrovirus virion and genomic structure. (Panel A). Structure of a
general retrovirus virion. (Panel B) Sequence features of a retroviral genomic
RNA (adapted from Coffin, 1991).
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The retroviral genome contains three main open reading frames which form
the gag,pol, and env genes (Fig. IB). These genes produce the structural proteins
and enzymes necessary for viral replication. Smaller open reading frames may also
be present which can produce auxiliary gene products such as the transactivation
protein (Tat) of HIV. The ends of retroviral genomic RNA are terminally
redundant. A non-coding region, R, at the capped 5' end is repeated again at the 3'
end of the genome just prior to the poly-adenine tail. R is followed at the 5' end by
U5 and non-coding leader regions, while it is preceded at the 3’ end by the U3
region. U5 contains the poly-adenylation signal sequence while U3 contains the
viral promoter and enhancer elements necessary for transcription of the viral
genome after infection (Coffin, 1991).
Reverse Transcription and Integration
The unique mechanism by which retroviruses replicate is one of the most
defining characteristics of this viral family. Upon penetration of the host cell, the
viral genomic RNA undergoes reverse transcription to form a double-stranded
DNA copy or provirus. This process originates at a host derived tRNA molecule
bound to a complementary primer binding site (PBS) which lies adjacent to the 5'
U5 region. This bound tRNA serves as the primer for the viral reverse transcriptase
enzyme which begins to create a DNA strand complementary (negative-sense) to
the viral RNA. As the U5 and R regions are copied, they are degraded by the viral
RNase H activity. Because the template is degraded as it is copied, the nascent
DNA strand dissociates from the template when the 5' end is reached. The nascent
DNA strand is then free to re-associate with the complementary R region at the 3'
end of the template and reverse transcriptase continues to elongate the
complementary DNA strand. This is referred to as strand jumping. During the
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synthesis of negative-strand DNA, a positive-strand is being produced as well. The
RNase H activity cleaves the template RNA at a precise point adjacent to the U3
region. This recognition sequence is referred to as the poly-purine tract due to its
tendency to contain strings of adenine and guanine residues. The cut template
RNA and negative-stranded DNA form the primer complex for reverse
transcriptase. After the U3, R, U5, and PBS regions have been successfully copied,
the positive-strand DNA jumps to complementary sequences at the opposite end of
the negative-strand DNA. Both positive and negative DNA strands are then
completed by reverse transcriptase to form the provirus. Not only is this
mechanism unique due to its reversal of the conventional flow of genomic
information, but it also results in a rearrangement of the viral genome at the same
time. Unlike the RNA genome, the U3, R and U5 regions are clustered together
and repeated at both ends of the provirus. Collectively, these three regions make up
the long terminal repeat or LTR.
After being copied into a proviral form, the retrovirus integrates itself into
the genome of the host. The exact mechanism by which this occurs is not
completely understood but it is known that the reaction requires both the viral
capsid as well as the integrase enzyme. Staggered cuts are made at both ends of the
provirus resulting in 5' overhangs. In a linked reaction, staggered cuts are made
within the host genomic DNA and these are linked to the cut provirus.
Subsequently, any gaps or nicks in the DNA are repaired by a host repair enzyme.
This results in an intact provirus, minus one to two base pairs from each end, being
inserted into the host’s genome. During this reaction, linear provirus can become
linked to itself forming a closed, circular piece of extra-chromosomal DNA.
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Within an infected cell, both these forms of provirus are readily detectable (Coffin,
1991).
Gene Expression
Once integrated into the host genome, the provirus uses the host’s own
transcriptional and translational machinery to create progeny virions. The U3
region of the LTR contains the single promoter for the entire retroviral genome. It
contains the TATA box as well as most, if not all, enhancer elements. As these
elements bind cellular transcription factors, they influence both the type and state of
the host cell in which the virus may be transcribed as well as the rate at which
transcription occurs. The actual transcription start site lies downstream of the
TATA box and forms the demarcation between the U3 and R regions.
Transcription then proceeds through the proviral genome to the U5 region of the 3'
LTR which contains the poly-adenylation signal sequence. The point on the viral
mRNA where poly-adenylation begins forms the boundary between the R and U5
regions. This full-length transcript may be transported to the cytoplasm where it
forms the genomic RNA in progeny virions or be translated to produce the gag and
gag-pol polyproteins. In a minority of cases, a translational error may occur
resulting in the production of the pol gene products. Alternatively, the full-length
transcript may stay within the nucleus and be spliced to form a variety of smaller
viral mRNA species. These singly or multiply-spliced mRNAs are responsible for
the production of the env polyprotein as well as auxiliary proteins. Virion assembly
and subsequent budding occurs at the plasma membrane. Although the
polyproteins produced by gag, pol, and env undergo some proteolytic cleavage
prior to virion assembly and release, complete cleavage of the polyproteins and
maturation of the virion occurs after budding (Coffin, 1991).
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Taxonomy
The family Retroviridae is subdivided into three subfamilies; the
Oncovirinae, Lentivirinae, and Spumavirinae based on a variety of factors
including genomic complexity and pathology (Table 1).

Table 1. Retrovirus subfamilies
Subfamily

Isolates

Pathology

Oncovirinae

Rous sarcoma virus

acute, exogenous

Rous-associated virus 1-50

non-acute, exogenous

Feline leukemia virus

non-acute, exogenous

Mouse Mammary tumor virus

non-acute, exogenous

Bovine leukemia virus

non-acute, exogenous

Human T-cell leukemia virus

non-acute, exogenous

Rous-associated virus type 0

benign, endogenous

Lentivirinae

Human immunodeficiency virus
Simian Immunodeficiency virus
Feline immunodeficiency virus
Visna/maedi virus
Equine infectious anemia virus

Spumavirinae

Human foamy virus
Simian foamy virus

Oncoviruses have been identified in a variety of animal species including
humans and although usually exogenous, certain strains such as Rous-associated
virus type 0 are endogenous. Many oncoviruses, but not all, cause transformation
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of in vitro cell cultures and induce tumors within their natural hosts. While some
oncoviruses actually contain oncogenes and rapidly cause disease, there are many
members that do not encode oncogenes but are still involved in tumorigenesis and
still others that cause no disease at all. Therefore they are classified as acute, non
acute, and benign. Most oncoviruses are genetically quite simple. Few produce
any auxiliary proteins other than an oncogene. HTL V, the causative agent of adult
T-cell lymphoma, is one of the most complex oncoviruses in that it produces two
auxiliary proteins Tax and Rex. Both of these proteins perform regulatory
functions. Tax interacts with cellular transcription factors, bound to specific ciselements within the U3 region, and stimulates transcription. The presence of Rex
results in the production of more full-length or singly-spliced viral mRNA
transcripts relative to the multiply-spliced transcripts that produce itself and Tax.
These proteins are similar to those produced by lentiviruses (Coffin, 1991).
Lentiviruses are probably the most significant subfamily of retroviruses
from a pathology standpoint as this group includes the HTV virus, the causative
agent o f the acquired immunodeficiency syndrome (AIDS). Since its discovery in
the early 1980s, HIV is believed to have infected more than 13 million people
world-wide. By the year 2000, that number may reach 40 million. Despite intense
research efforts this virus continues to exhibit a fatality rate of nearly 100%
(Cowley et al., 1995). Lentiviruses differ significantly from the oncoviruses in
pathology and genomic complexity. These viruses usually cause slow, progressive
infections that can lead to auto-immune or immunodeficiency diseases within the
host. They are also more genetically complex than the oncoviruses because they
produce a number of auxiliary proteins. The most universal of these proteins are
Tat and Rev. The HTV Tat protein, in conjunction with cellular proteins, interacts
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with a stem-loop structure, the transactivation response element (TAR), contained
in nascent viral mRNA transcripts and may either stimulate initiation of
transcription or may prevent premature termination by the RNA polymerase II
complex (Laspia et al., 1989; Selby et al., 1989). This mechanism is not universal
among lentiviruses. In the case of Visna/Maedi virus for example, there is no TAR
element present and the analogous Tat protein acts indirectly at the viral LTR in a
mechanism similar to that of HTLV Tax. Despite these differences, the lentivirus
Tat protein dramatically increases viral mRNA production. Rev also acts upon
viral mRNA at a region of extensive secondary structure, the rev-responsive
element (RRE), and facilitates the transport of viral mRNA into the cytoplasm and
the subsequent loading of polysomes (Tiley et al., 1992). This results in an
increase in the ratio of full-length or singly-spliced viral mRNA to multiply-spliced
viral mRNA thereby increasing production of the structural proteins while
decreasing the production of auxiliary proteins such as Tat and Rev (Perkine et al.,
1989). Most lentiviruses are also believed to produce a viral infectivity factor, Vif.
This small protein is packaged within the virion and appears essential for viral
infectivity in vivo as mutations in Vif can prevent spread of the virus (Von
Schwedler et al., 1993). In addition to Tat, Rev, and Vif, the primate lentiviruses
SIV (Simian immunodeficiency virus) and HTV produce the auxiliary proteins Nef,
Vpu, and Vpr/Vpx. The genes which produce these proteins are often dispensable
in vitro thus they have not been as extensively studied as Tat and Rev but they
appear to dramatically affect virulence in vivo. Nef was originally identified as a
negative regulatory protein that acted upon the LTR to decrease transcription
initiation. A theory that remains somewhat controversial. N ef is also believed to
play a role in the endocytosis and lysosomal degradation of CD4, the primary
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cellular receptor for HIV and SIV (Nebreda et al., 1991). Vpu is a protein unique
to HIV-1 and appears to perform two different functions. It is involved in both
virion egress as well as degradation of intra-cellular CD4 (Vincent et al., 1993).
Virtually nothing is known about the in vivo function of Vpr (HIV-1 and HTV-2)
and Vpx (HIV-2 and SIV), although some studies have shown that Vpr may act
upon the HIV LTR to enhance transcription (Clements and Payne, 1994).
The least information is known about the subfamily Spumavirinae, or
foamy viruses. Viral isolates belonging to this family have been isolated from a
wide variety of species including humans. Although they have not been shown to
cause disease, although a study of patients suffering from nasopharyngeal
carcinoma indicated a high prevalence Human foamy virus (HFV) positive
individuals. This may indicate an involvement in tumorigenesis. They are dubbed
foamy viruses due to their cytopathogenic effects when propagated in tissue culture.
Similar to lentiviruses on a genomic level, the foamy viruses are believed to
produce at least three auxiliary proteins including one that functions as a
transactivator similar to Tat (Aquzzi, 1993).
Equine Infectious Anemia Virus
Equine infectious anemia, first described in 1843, is a persistent disease
affecting members of the genus Equus. In 1904, the disease was linked to a
filterable agent, the Equine infectious anemia virus. The virus is transmitted to
susceptible hosts by contaminated blood, the main vector being hematophagous
insects, where it infects cells of the monocyte/macrophage lineage (Sellon et al.,
1994). Diagnostic tests, the agar gel immunodiffusion and competitive ELISA
tests, are required by federal quarantine laws governing the interstate transport of
animals. Estimates place the percentage of infected horses, within the United
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States, at between 0 and 2% depending upon geographic location (Loftine et al.,
1990).
Horses with EIA may undergo three different phases of the disease. Within
30 days of the initial infection, the horse may develop high titer viremia resulting in
fever, weight loss, thrombocytopenia, and severe anemia. This is the acute phase of
the disease and in severe cases may be fatal. EIA is unique among lentiviral
syndromes due to this rapid emergence of clinical disease. Horses that recover
from the initial febrile episode may experience additional disease episodes at
irregular intervals during the first year of infection. Horses that experience multiple
and severe febrile episodes are described clinically as being in the chronic stage of
EIA. Both the number of episodes experienced during this phase and the time
interval between them varies. During the 1980s, researchers discovered that
emergence of antigenic variants of the virus corresponds to sequential disease
episodes (Montelaro et al., 1984). Thus EIA became the first disease of lentiviral
etiology whose persistence was linked to the antigenic variation of the virus.
Horses which harbor the virus yet show no visible signs of disease are described as
being asymptomatic. Asymptomatic horses can have a recurrence of clinical
symptoms should they become immuno-compromised at some point in their
lifetime. In addition, asymptomatic horses are capable of transmitting the disease
and therefore serve as a reservoir for the virus.
The clinical symptoms of EIA are believed to result from widespread
immune system activation within the host in response to viremia. Complement
coated erythrocytes are present in horses during the acute and chronic phases of the
disease. It is believed that viral glycoproteins or viral glycoprotein/antibody
complexes associate with the surface of erythrocytes eventually resulting in
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complement mediated lysis or phagocytosis of the affected erythrocytes (Sentsui
and Kono, 1987). In addition to hemolysis, anemia in horses with EIA is
exacerbated by a decrease in erythrocyte precursors. As viral proteins do not
appear to be associated with immature erythrocytes, the reason for their depletion is
unknown but may be due to an activation of macrophages and subsequent release of
factors, interleukin 1 and lactoferrin, that affect iron metabolism (McGuire et al.,
1969). A decrease in platelet count, thrombocytopenia, is caused by a similar
immune-mediated mechanism. During disease episodes, host platelets are bound to
excessive amounts of IgG and IgM which may cause their subsequent removal by
phagocytosis (Clabough etal., 1991; Sellon etal., 1994).
Structure
EIAV is classified as a Ientivirus based on pathology, morphology,
serology, genetic organization, and enzymatic activities. It is an enveloped RNA
virus, approximate diameter 140 nm, with a conical core. The exterior envelope is
derived from the plasma membrane of the host cell and is studded with
glycoprotein spikes. The viral glycoprotein gp90 forms the exterior domain of the
surface spike while the transmembrane segment is formed by gp45. Both are
cleaved from a precursor poly-protein encoded by the env gene. The conical core
of EIAV is formed from four non-glycosylated proteins, p26, pi 5, pi 1, and p9,
which are products of the gag gene. In addition, the core contains the pol gene
products which include the reverse transcriptase, protease, deoxyuracil
triphosphotase (dUTPase), RNase H, and integrase enzymes. EIAV also produces
two regulatory proteins whose functions are analogous to HIV Tat and Rev, as well
as possibly two auxiliary proteins of unknown function (Ttm and the ORF S2
product). The diploid RNA genome consists of capped and poly-adenylated RNA
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8.2 kb in length. The exact processes of reverse transcription and integration have
not been elucidated for EIAV but it is believed to behave similarly to that of other
lentiviruses (Sellon et al., 1994).
Genomic Organization and Expression
The EIAV proviral genome (Fig. 2), like all lentiviruses, is subject to a high
degree of sequence variability both within a single host and throughout a host
population. Therefore the nucleotide lengths discussed hereafter must be
considered approximations. The genome begins with a 5' LTR region which varies
in length, approximately 300-330 bp, between different virus isolates. This is
followed by a leader sequence, 143 bp long, which contains a splice donor site used
in subsequent viral mRNA splicing reactions and the first exon of the EIAV tat
gene. The leader region ends at the ATG initiation codon for the gag gene. This
gene, approximately 1500 bp in length, encodes a precursor polyprotein which
yields the four core proteins upon proteolysis. Overlapping the gag gene by 251 bp
is the pol gene. Approximately 3400 bp in length, this gene produces the protease,
reverse transcriptase, RNase H, dUTPase, and integrase enzymatic activities. The
dUTPase enzyme is only present in a sub-set of the lentivirus group of viruses.
Those viruses that infect macrophages such as EIAV and Feline immunodeficiency
virus (FIV) may require this enzyme in order to replicate in this terminally
differentiated and non-replicating cell type. Immediately following the pol gene is
a small open reading frame designated as ORF SI which is only about 150 bp long
and lacks its own initiation codon. This region forms the second exon of the EIAV
tat gene. Following the stop codon of ORF SI by about 7 bp is another short open
reading frame ORF S2. This 200 bp region could potentially produce a 66 amino
acid protein which bears no sequence homology to other known lentiviral proteins
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Figure 2. Schematic diagram of the EIAV pro virus and transcripts. Open reading
frames and their products are illustrated for the proviral genome followed by
diagrams of possible transcripts produced as well as their respective protein
products.
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and has no known function although it has been hypothesized to be the EIAV
equivalent of Vif. ORF S2 almost completely overlaps the env gene. The env gene
of EIAV is approximately 2600 bp long and produces the polyprotein gpl35 which
is subsequently cleaved to form the surface protein gp90 and the transmembrane
protein gp45. Within the env gene region lies another overlapping open reading
frame, ORF S3, approximately 400 bp long. This region, like ORF SI, contains no
initiation codon but with subsequent splicing of the mRNA forms a large portion of
the putative EIAV rev gene. After the stop codon of env lies a short region 17 bp
long, containing the poly-purine tract, which is followed in turn by the 3' LTR
(Sellon et al., 1994).
In addition to the main structural and enzymatic proteins, the genome
encodes a number of auxiliary proteins similar to other lentiviruses. In order to
accomplish this, EIAV utilizes several splice donor and acceptor sites to create
singly and multiply-spliced mRNAs (Fig. 2). To produce a functional tat gene, the
splice donor site within the leader sequence is linked to a splice acceptor site at the
end ofpol. This creates a singly-spliced mRNA 3.2 kb in length that produces tat
and env gene products. To produce the putative Rev protein, the splicing
machinery uses the splice donor site within the leader sequence as well as the splice
acceptor site at the end of pol to remove the gag and pol regions as previously
discussed for the 3.2 kb mRNA. In addition, a splice donor site at the end of ORF
SI is linked to a splice acceptor site just downstream of ORF S2. Finally, a donor
site in env is linked to an acceptor site at the beginning of ORF S3. This creates a
mRNA species containing the leader sequence linked to ORF SI, then to
approximately 100 bp of env, and ORF S3. This multiply-spliced, 1.5 kb mRNA
species is believed to produce both an intact Tat protein in addition to Rev. Two
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additional species of viral mRNA have been identified in infected cells. One is
multiply-spliced and similar to the mRNA that produces Tat and Rev but it lacks
the first exon of rev. Therefore it is believed to produce only Tat. The other is a
singly-spliced mRNA produced by the splicing of the leader sequence directly to
the C-terminal portion of env. This mRNA produces a chimeric protein of
unknown function, dubbed Ttm, encoded by the first exon of tat and the C-terminal
portion of env (Derse et a l, 1993).
Tissue Tropism
EIAV infects peripheral tissue macrophages in vivo. Within chronically
infected horses, viral antigen can be detected in lymph nodes, kidney, liver, lung,
thymus, bone marrow, adrenal, stomach, pancreas, cerebrum, cerebellum, pituitary
gland, and spleen. The highest concentrations are within the spleen, liver, lymph
nodes, and bone marrow. All these tissues are enriched with peripheral
macrophages. Hybridization studies indicate that viral antigen is localized to
macrophage-like cells within these tissues. Analysis of viral DNA and in situ
hybridization studies agree with this tissue distribution and localized viral mRNA
to mature tissue macrophages exclusively (Sellon et al., 1994).
Sequence Variation
Like all retroviruses, EIAV isolates demonstrate a great degree of sequence
divergence. In some cases, sequence divergence results in an altered phenotype and
the creation of a new quasi-species or strain of the virus. Pair-wise sequence
comparison between sequential EIAV isolates from an infected horse indicated a
sequence variation as high as 1.43% overall. Much of this variation was localized
to the env and LTR regions which, individually, showed sequence divergence rates
as high as 5.6% (Payne et al., 1987). The high degree of sequence variation is
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believed to result from the error prone nature of the reverse transcriptase enzyme
coupled to selective pressure by the immune system of the host. The retrovirus
reverse transcriptase enzyme lacks any exonucleolytic proofreading activity and can
have in vitro misincorporation rates as high as 1 in 1000 nucleotides. In addition,
the unique nature of retrovirus replication, involving the transfer of nascent DNA
strands to other locations in the genome, leads to a high degree of recombination
and rearrangement. Although no exact measurement has been made of the
frequency of these events, one study found that approximately 50% of HIV-1
proviruses isolated from an individual contained some sort of sequence
rearrangement such as a deletion, addition, or duplication. In many cases, these
aberrations create unique viral phenotypes by changing the cytopathogenicity,
tissue tropism, or replication capacity (Coffin, 1991).
In Vitro Propagation
Propagation of virulent EIAV field isolates in vitro is extremely difficult.
Leukocyte cultures have a very short life-span, approximately 10 to 12 days, and
,when infected with EIAV, can demonstrate rapid, within 72 hours post-infection,
cytopathogenic effects. Due to this difficulty, Malmquist et al. (1973) adapted the
Wyoming strain, a highly virulent field isolate, for growth in an equine dermis (ED)
cell line. The ability to replicate in equine fibroblasts corresponded to a severe
decrease in virulence. Subsequently, it was found that this Prototype strain was
able to establish persistent, non-cytopathogenic infections in feline embryonic
(FEA), fetal canine thymic (Cf2Th), and fetal equine kidney (FEK) cell cultures.
The Prototype strain is also able to replicate in fetal donkey dermal (FDD) cells
cultures but induces cytopathogenic effects within 22 days post-infection. Multiple
passage of Prototype in FDD cell cultures led to a new virus strain, the FDD-
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adapted strain, which demonstrates cytopathogenic effects within 12 days post
infection. Most recently, a number of EIAV molecular clones have been
developed. Although infectious, none of these clones appear to cause disease
(Sellon etal, 1994).
Cytopathogenicity
As little is known of retrovirus cytopathogenicity, the mechanism by which
it occurs and the viral determinants that influence it are of considerable scientific
interest. There are probably several different mechanisms by which retroviral
infections can induce cell death and therefore the viral determinants that influence it
may differ from one system to another. Experimental studies usually involve the
exchange of gene segments between cytopathogenic and non-cytopathogenic
strains. Numerous studies of this type have been performed on primate lentiviruses
with very diverse results. Genetic regions that influence cytopathogenicity have
been found throughout the lentivirus genome but are most often localized to the
transmembrane, TM, and surface, SU, proteins produced by the env gene. The TM
protein of retroviruses contains a membrane spanning region in its amino terminus
that mutational analysis indicates is responsible for cell to cell fusion or syncitia
formation in primate lentivirus infected cell cultures. In addition, the TM protein
contains a region near its carboxyl terminus that may form an amphipathic helix.
Should these helices aggregate within the plasma membrane and form channels,
they would have a deleterious effect on the osmotic pressure across the plasma
membrane. This theory explains why some cells infected with HIV demonstrate a
large increase in cell volume prior to cell death. Studies performed with HIV
strains containing deletions in the carboxyl terminus of the SU protein demonstrate
syncitia formation but show an attenuation in the production of enlarged single
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cells (Garry, 1989). Not all cytopathic infections demonstrate the physical changes
within the host cell required by the two previous theories. It has also been
proposed that the HTV SU protein may induce programmed cell death or apoptosis
in both T-cells and neural cells when bound in excessive amounts to the HTV
receptor molecule CD4. This effect can be mimicked by incubation of these cell
types with anti-CD4 antibodies (Gougen, 1993). The viral determinants of
cytopathogenicity are not exclusively limited to the structural genes however.
Some cytopathogenic infections seem to be caused by an over-expression of the
virus. There are examples of cytopathic HTV infections which produce an
estimated 2.5x 106 copies of viral mRNA per cell or levels of viral protein as high
as 40% of the cellular total. In these cases, it is possible that the cell is simply
being overwhelmed by viral products resulting in a shutoff of host protein
production and inevitable cell death. This situation is believed to occur when the
host cell loses its resistance to super-infection (Garry, 1989). Most retrovirus
infections lead to a down-regulation of the host protein that acts as the virus
receptor which prevents a cell from being infected multiple times or super-infected.
In studies with cytopathogenic avian retroviruses, excessive amounts of un
integrated proviral DNA was found in the cytoplasm of infected cells indicating
multiple rounds of viral infection. Subsequent experiments with UV irradiated
virus capable of infection and reverse transcription but deficient in gene expression
indicated that the presence of a large amount of viral proviral DNA was not, in
itself, cytopathogenic. It is possible that super-infection of a host cell also leads to
over-expression of viral mRNA or viral gene products causing cell death. The viral
determinants which control the host cells resistance to super-infection are, once
again, usually located within the env gene. Mutations in env may lead to a change
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in receptor recognition allowing the virus to circumvent the previous downregulated receptor (Coffin, 1991).
The accelerated cytopathogenic effects induced by the FDD-adapted virus
strain provides an interesting system for studying factors that influence virus
cytopathogenicity. Perry et al (1992) examined the sequence differences between
Wyoming strain proviral DNA, propagated in horse macrophage cultures, and the
infectious molecular clone CL22, which is capable of replicating in ED cells and is
not virulent. The results indicated that both the gag and pol regions were relatively
conserved, with only 0.26% and 0.67% nucleotide difference respectively. Most of
the sequence divergence occurred within the env and LTR regions. The surface
protein, gp90, region of env showed a nucleotide difference of 5.57%, an amino
acid difference of 11%, while the LTR indicated a divergence of 5.14% to 5.30%.
These results are in approximate agreement with those obtained from other studies
examining sequence changes upon tissue culture adaptation or disease progression
within the host. These studies all agree that the LTR and env, including the S3
ORF, are prone to a high degree of sequence variability. As gp90 is essential in the
process of host cell recognition and attachment, it would seem logical that changes
within this protein are necessary for any change in cell tropism such as tissue
culture adaptation. Unfortunately, replacement of the CL22 gp90 coding region
with the corresponding region from Wyoming strain proviral DNA resulted in a
molecular clone still capable of infecting ED cells. Although this result was
surprising, it seemed to agree with the data obtained on the FDD-adapted strain of
EIAV.
In a previous study, the cytopathogenic infection of FDD cell cultures by
FDD-adapted virus was compared to the persistent infection of FEK cell cultures
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by Prototype virus. Rasty et al. (1990) reported, as determined by
immunofluorescence studies, that in the cytopathogenic infection approximately
30% o f the cell population was EIAV antigen positive while in the persistently
infected cell culture almost 100% of the cell population exhibited EIAV antigen.
This result was supported by data obtained by Southern hybridization analysis of
total cellular DNA isolated from infected cultures. These results indicated
approximately one third the amount of proviral DNA in the cytopathogenic
infection relative to the persistent infection. Evidence indicated that the viral
determinants which affect the cytopathogenicity of the FDD-adapted strain are
probably not involved in cell recognition, attachment, or penetration of the virus as
the percentage of cells infected in the cytopathic infection was actually less than
that o f the persistent infection and there was no accumulation of viral DNA
indicative of super-infection. In addition, FDD cell cultures infected with the FDDadapted virus did not demonstrate the morphological changes such as cell swelling
or syncitia formation indicative of some cytopathic HIV infections. All this
evidence seemed to discount the env region as the likely candidate responsible for
the behavior of the FDD-adapted virus.
The study by Rasty et al. (1990) did reveal some possible explanations for
the behavior of the FDD-adapted virus strain. Using Northern hybridization
analysis, it was shown that FDD cell cultures infected with the FDD-adapted virus
produced approximately 30 times as much viral mRNA as FEK cell cultures
persistently infected with the Prototype virus. In addition, the cytopathogenic
infection produced detectable levels of viral mRNA much earlier in infection. This
was a very interesting result in light of some theories about the mechanism of
retrovirus cytopathogenicity which indicate that the over-production of viral mRNA
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or viral gene products is cytotoxic. One region of the genome that directly
influences the production of viral mRNA is the long terminal repeat.
Long Terminal Repeat
The most characterized lentivirus LTR is, of course, that of HIV. The HIV
LTR contains a core enhancer/promoter region in its U3 region approximately 90
nucleotides in length that is centered 65 bp upstream of the RNA cap site. This
core unit contains the TATA box, two NF-kB and three SP-1 binding motifs and is
essential for virus replication.
NF-kB is constitutively expressed in all mammalian cells yet plays a major
role in restricting the replication of HTV to cell types involved in immune system
functions such as T-lymphocytes and monocytes. Its level of expression is highest
in B- and T- lymphocytes where it induces expression of the immunoglobulin k,
interleukin-2a receptor, and interleukin-2 genes. In most cell types, including un
activated T-cells, it is associated with an inhibitor protein, I-kB, which masks its
nuclear localization signal causing it to be retained in an inactive state within the
cytoplasm. T-cell activation leads to the phosphorylation and degradation o f I-kB
allowing NF-kB to migrate to the nucleus and stimulate transcription. A similar
effect can be induced in other cell types by treatment with mitogens, cytokines, or
other activating agents. In monocytes, NF-kB binding activity is induced by HIV
infection itself. These elements are not necessary to maintain active viral
replication of the virus in vitro but are required to activate transcription from the
latent provirus.
Three tandem Sp-1 binding sites, which behave as proximal promoter
elements, lie immediately downstream of the NF-kB sites. Although Sp-1 is a
ubiquitous transcription factor and stimulates expression of a number of cellular
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genes, its expression is usually the highest in cells undergoing terminal
differentiation. This protein contains a zinc-finger structural motif which
recognizes DNA regions rich in GC dimers. Of the three Sp-1 binding sites, only
the two sites proximal to the HTV promoter are active. It is essential for viral
replication that one of these two binding sites be maintained and in close proximity
to the TATA box as Sp-1 interacts directly with TATA box binding protein
associated factor 110. It has been suggested that Sp-1 acts to stabilize pre-initiation
complexes. The complete absence of these sites eliminates promoter activity under
both basal and transactivated conditions. Sp-1 is also capable of interacting in a
synergistic manner with other transcription factors bound to more distal elements
such as NF-kB, Ets-1, or additional Sp-1 monomers.
Approximately 24 bp upstream of the transcriptional start site is the HTV
TATA box. Similar to other eukaryotic promoters, the HIV TATA box binds the
TATA box binding protein (TBP) component of transcription factor IID (TFIID)
and provides the location for the assembly of the RNA polymerase II complex. The
actual role of the TATA element is somewhat more complex however as mutations
within this region that do not effect basal transcription can dramatically reduce
transactivation by Tat. In addition, mutations within this region that do reduce
basal transcription can be corrected for by corresponding mutations within the Sp-1
sites. These experiments strongly suggest interactions between the RNA
polymerase complex at the TATA box and both Sp-1 and Tat. The TATA box of
HIV is flanked on both sides by palindromic E box motifs (CANNTG) which have
also been shown to bind cellular proteins that stabilize the TFIID complex while
displacing TBP. Mutations within these motifs effect transcription under both basal
and transactivated conditions.
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Overlapping the TATA region is the initiator element or SSR (start site
region). Originally identified in the terminal deoxynucleotidyl transferase gene,
this element allows the initiation of transcription in the absence of a TATA box.
The RNA polymerase complex formed on this element differs from the complex
formed at the TATA box in that it does not respond to transactivation by Tat. This
complex has only been demonstrated in vitro.
Downstream of the transcription start site, nucleotides +1 to +59, is the
TAR element of HTV-1. TAR forms a stem-loop structure in nascent viral RNA
that is essential for viral replication and is both proximity and orientation
dependent. The actual structure rather than the sequence is most important for
activity although the nucleotides comprising the loop are important as is a uracil
residue within a three nucleotide bulge on the stem region. It is this bulge that
actually binds the viral protein Tat while the loop region is known to bind a variety
of other cellular factors. Competition studies show that TAR DNA fails to inhibit
Tat recognition of TAR RNA thereby proving that TAR functions primarily as an
RNA element. The exact mechanisms by which the Tat/TAR complex acts to
enhance viral expression could involve both transcript elongation and initiation. In
the absence of Tat, the HIV-1 promoter produces a large amount of short transcripts
comprising only the region between the transcription start site and TAR. This
region has been named 1ST for inducer of short transcripts and mutations within
this region interfere with short transcript accumulation. In the presence of Tat, the
number of short transcripts decreases and longer viral RNA transcripts
predominate. Experiments have also shown that Tat is able to modify transcription
factor complexes artificially stalled at TAR allowing them to elongate. Both of
these observations indicate that the Tat acts to elongate stalled HIV-1 transcripts
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probably through interactions with transcription factors TFIIF and TFIIS.
Presumably, TAR simply acts to bind Tat and bring it into close proximity with the
HIV promoter. Other studies indicate that Tat may stimulate transcription initiation
as well. Mutations mapping to the TATA or Sp-1 binding regions can influence
transactivation without influencing basal transcription. These synergistic
interactions between upstream elements and Tat may implicate it in transcription
complex assembly. Therefore, Tat may act to stimulate transcription initiation as
well as elongation.
The remainder of the U3 region (upstream of the core region) contains an
array of possible transcription factor binding sites such as those for, LEF, Ets-1 or
Ets-2, and AP-1. Mutational analysis of these sites often yield variable results
depending on cell type and, in some cases, these sites negatively regulate
transcription. Therefore the relevancy of these sites is still controversial. It has
been speculated that these sites confer responsiveness of the LTR to diverse cellular
signals allowing for changes in cellular tropism (Antoni et al., 1994; Garcia and
Gaynor, 1994; Gaynor, 1995; Jones and Peterlin, 1994).
Of the transcriptional activators that bind to elements upstream of the core
enhancer/promoter region, one of the most interesting may be the lymphoid
enhancer factor 1, LEF-1. Identified in human T- and B- cells, this factor does not
seem to enhance transcription itself but acts synergistically with other enhancer
elements in close proximity such as the Ets-l site. LEF binding induces a bend
within the DNA of 110°. This is believed to facilitate the protein-protein
interactions between upstream enhancer elements and proximal promoter elements
such as Sp-1. In support of this mechanism, a minimum distance is required
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between LEF and the promoter as deletion of the intervening DNA abrogates LEF
function (Giese et al., 1992; Jones and Peterlin, 1994).
Ets-1 is a member of the proto-oncogenic ets family of transcription factors
which includes Ets-1 and 2, PU.l, Spi-l, Elf-1, PEA3 and others. Members of this
family have been linked to a variety of steps involved in hematopoeisis especially
myeloid and lymphoid cell specific gene expression. PU.l, for example, upregulates the production of the macrophage colony stimulating factor receptor and
the macrophage scavenger receptor during macrophage differentiation. Another
family member, Elk-1, binds to the serum response element upstream of c-fas.
Little is known about the mechanisms by which these proteins are regulated.
During B-cell activation, phosphorylation of Ets-1 by caseine kinase II results in its
release from the DNA. In T-cells however, Elf-l is sequestered by the underphosphorylated form of the retinoblastoma protein, Rb. Upon T-cell activation, the
phosphorylation of Rb leads to the release of Elf-1 allowing it to activate
transcription. These proteins are believed to contain helix-tum-helix structural
motifs which interact with the DNA. The minimal consensus core sequence
recognized by these factors is C/A GGA A/T but nucleotides in proximity to the
core motif may influence exactly which factor binds to a given site as multiple
members of the ets family may be present within the same cell type. However, in
the case of the immunoglobulin heavy chain enhancer, multiple ets proteins are
capable of binding at the same recognition site. Ets recognition sites are often
found in multiples and in close proximity to other transcription factor binding sites,
such as those for AP-1 and Sp-1, with which they often act in synergy. In the
HTLV-1 LTR, Ets-1 or Ets-2 interact cooperatively with Sp-1 to activate
transcription. Combinatorial interactions between ets proteins and AP-1 have been
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demonstrated to activate transcription of polyoma virus, granulacyte-macrophage
colony stimulating factor, and the macrophage scavenger receptor (Jones and
Peterlin, 1994; Moreau-Gachelin, 1994; Wang et al., 1994; Wu et al., 1994).
AP-1, originally human activating protein I, is a transcription factor formed
primarily from the products of the c-fos and c-jun proto-oncogenes. AP-1 protein
complexes are usually Fos/Jun heterodimers but may also consist of Jun/Jun
homodimers. Both Fos and Jun contain a leucine zipper motif flanked by basic
residues which form the region where protein dimerization and DNA binding occur.
Similar motifs are found in other transcription factor families such as ATF, CREB,
and the glucocorticoid receptor. Due to this similarity, Fos and Jun are capable of
forming complexes with these proteins as well. Although the consensus
recognition sequence for AP-l is TGACTCA, the heterogeneous nature of the
protein complex itself and the influence of surrounding nucleotides leads to a large
degree of variability in AP-1 recognition sites and its effect on transcriptional
activity. AP-l complexes, in conjunction with the glucocorticoid receptor, can
actually inhibit transcription of the proliferin gene. AP-l activity in cell cultures
may be temporarily induced by treatment with protein kinase C activators such as
phorbol esters but its regulation on the cellular level is much more complicated than
its state of phosphorylation as both fo s and jun are auto-regulatory and affect the
expression of several other transcription factors (Kerppola and Curran, 1991).
At the time this study was initiated, very little was known about the
transcription factor complexes formed by the EIAV LTR. Compared to other
lentiviruses, it is quite short with a U3 region of approximately 200 bp, an R region
of approximately 80 bp, and a U5 region approximately 40 bp long. The average
length of a lentivirus U3 region is 450 bp, the R region 100 bp, and the U5 region
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70 bp in length (Coffin, 1991). The short length of the U3 region, where most ex
acting regulatory signals are usually confined, indicated that the transcription
factor-LTR complexes formed in the case of EIAV were probably fewer in number
relative to complex lentiviruses such as HTV. Derse et al. (1987) performed a
functional comparison o f two different LTR variants isolated from proviral DNA.
They identified the putative TATA box and poly-adenylation signals based on
sequence analysis and identified the RNA cap site by SI nuclease mapping. In
addition, they replaced the SV40 promoter sequences o f the CAT expression vector
pSV2/CAT with the LTRs and quantitated their transient expression levels in a
variety of cell lines. The results of this study indicated that the EIAV LTRs were
very weak promoters relative to the SV40 virus promoter in all the cell lines tested
but their activity was greatly enhanced, by over 200 fold, when the cell cultures
were infected with EIAV. This was the first evidence that EIAV produces a
product which transactivates its LTR. In a following study, Sherman et al. (1988)
used deletion mutants of the LTR coupled to the CAT gene to demonstrate that
deletion of the U5 and R regions abrogated transactivation in a Cf2Th cells. The
transactivation response element was further localized by deletion studies in FEA
cells to the R region (Dorn and Derse, 1988). More recent studies have since
identified the TAR element of EIAV as a stem-loop structure formed by
nucleotides +1 to +25. Similar to HIV-1, EIAV Tat interacts with an RNA element
and requires additional cellular factors such as Tat associated protein kinase TAK
(Herrmann, 1995; Derse et al., 1993). Although much work was performed
identifying the TAR and tat regions of the genome, very little attention was given
to identifying the basal transcriptional complexes formed by the LTR. In FEA cell
cultures, progressive deletions indicated that sequences upstream of position -111
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were dispensable for basal promoter activity. Deletion of an additional 35 bp
produced an LTR mutant almost twice as active as the un-modified version
indicating the presence of a negative regulatory element. Further removal of
sequences to positions -41 or -31 resulted in mutants whose promoter activities
were only about half the original while deletion of regions downstream of the
transcriptional start site had no significant effect (Dorn and Derse, 1988). These
results were similar to those obtained by a study of LTR deletion mutants in Cf2Th
cells. This study also showed that regions downstream of the cap site were
dispensable for basal transcription and that deletion of U3 sequences upstream of
position -50 removed a negative regulatory element and created a deletion mutant
with a much stronger promoter activity than the original LTR (Sherman et al.,
1989).
During the course of this investigation, several studies were published
which identified putative transcription factor binding sites in the EIAV LTR. These
studies were performed in canine osteosarcoma (D17), human epithelial carcinoma
(HeLa), human monocytic (U937 and THP-1), equine fibroblast (equine 6288), and
human B-cell (Raji) cell lines as well as primary horse mononuclear cell cultures
(PBMC). Using an LTR isolate derived from a non-infectious proviral DNA clone
of EIAV, XI2, Carvalho and Derse (1993a) identified four regions protected from
DNase 1 digestion by D17 nuclear extracts. Three protected regions are upstream,
but within 100 base pairs, of the transcription start site while the fourth region is
immediately downstream.
Based on recognition site homology, the first protected region (nucleotides 98 to -86) was believed to overlap with a binding site for the methylated DNA
binding-protein (MDBP). This conclusion was supported by subsequent
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electrophoretic mobility shift assays (EMSA) using D17, Raji, and THP-1 nuclear
extracts. The protein-DNA complexes formed by the extracts were inhibited by the
addition o f an oligonucleotide containing a previously characterized MDBP binding
element. In addition, deletion of sequences upstream of nucleotide -76 reduced
promoter activity 38% and 58% in D17 and HeLa cells respectively, using transient
gene expression assays. Subsequently, MDBP has been shown to be an isoform of
histone protein HI (Bruhat and Jost, 1995; Jost and Hofsteenge, 1992). This may
reconcile this study with those previous in which a negative regulatory element was
identified. The complete assembly of histone complexes would depend upon
cellular conditions and could inhibit initiation o f transcription from the LTR.
The second protected region (nucleotides -81 to -60) was postulated to
contain two polyomavirus enhancer A factor 2 (PEA2) binding elements (Carvalho
and Derse, 1993a). The protein which recognizes this element is a member of the
same family of transcription factors as the Caat box binding protein (Merriman et
al., 1995). An oligonucleotide containing these elements formed protein-DNA
complexes with D17, equine 6288, and THP-1 but not with HeLa and Raji nuclear
extracts. Formation of these complexes was inhibited by co-incubation with an
oligonucleotide based on LTR nucleotides 2 to 27 which is the fourth protected
region. Therefore, the binding element contained within nucleotides 2 to 27 is also
a putative PEA2 binding site. Deletion and mutation analysis indicate that the
second protected region behaves in a complex manner. Mutation of each site
individually, PEAmutl and PEAmut2, resulted in no change in promoter activity in
D17 cells while PEAmut2 reduced activity by 75% and PEAmutl increased activity
by 170% in HeLa cells. Complete deletion of both sites (nucleotides -76 to -63)
reduced activity by 40% in D17 cells, 50% in THP-1 cells and by 95% in HeLa
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cells. The conclusions drawn from these results is that this region is very important
for promoter activity but that different element(s) within or overlapping this region
are active depending upon the cell line used. The identification of the active
elements as PEA2 sites remains, at best, inconclusive.
The protected region in closest proximity to the TATA box contains, or is
adjacent to, three putative binding motifs: AP-1, PU.l and Oct. This region as a
whole was found to confer TPA responsiveness upon the LTR. Mutation of the
AP-1 motif (nucleotides -45 to -60) reduced promoter activity by 86%, 50%, and
95%, in D17, THP-1 and HeLa cells respectively. Nuclear extracts prepared from
D17 cells formed a protein-DNA complexes with an oligonucleotide based on LTR
nucleotides -40 to -67. Formation of this complex was only partially inhibited by
the addition of a competitor oligonucleotide containing a consensus AP-1 site
raising the possibility that this site binds different AP-1 heterodimers or multiple
transcription factors. The second half of this protected region was postulated to
contain a putative Oct motif overlapping a PU. 1 recognition element. Mutation or
deletion of this PU.l element reduced promoter activity by 80% or 51%,
respectively, in D17 cells whereas promoter activity was completely abolished in
HeLa and THP-1 cells. An oligonucleotide corresponding to LTR nucleotides -30
to -58 was found to form a complex pattern of protein-DNA complexes with D17
cell extracts. Competitor oligonucleotides containing either an Oct or a PU.l
recognition element were able to change the mobility shift pattern formed by LTR
oligonucleotide -30 to -58. On the basis of this data, it was postulated that in the
absence of PU.l, Oct could bind the vacated element (Carvalho and Derse, 1993a).
In a following study, Carvalho and Derse (1993b) showed that formation of
protein-DNA complexes with an oligonucleotide based on LTR nucleotides -35 to -
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46 by THP-1 and U937 cell extracts was abolished by pre-incubation with an
antiserum raised against PU.l and that PU.l expression by HeLa cells stimulated
transcription from the LTR by 10 fold. The definitive study of the PU.l element
was performed by Maury (1994) who utilized horse monocyte cell cultures and an
LTR isolate, derived from the macrophage cultures infected with the Th-1 field
isolate of EIAV, which contained three possible PU.l, an AP-1, and a PEA2
binding motifs. The maturation of the horse monocyte cell cultures was controlled
by the withholding or the addition of adult horse sera. Mobility shift assays
demonstrated that cultures which were allowed to mature to adherent macrophages
formed pronounced DNA-protein complexes with the three PU.l motifs of the LTR
but none with possible AP-1 and PEA2 motifs. Cultures held as monocytes did not
form these complexes at readily detectable levels. This study also showed that the
complexes formed at the PU.l sites were super-shifted by the addition of antiserum
against PU.l but not when incubated with serum against Ets-1 or Ets-2
transcription factors. Interestingly, mutation of all three possible PU.l binding sites
did not result in a drop in promoter activity under basal conditions, but eliminated
transactivation by EIAV Tat. Therefore, PU.l may directly interact with EIAV Tat.
Although there are a great many curious or contradictory results in all these studies,
it seems likely that provirus transcription in macrophages is controlled primarily
through the expression and subsequent binding of PU.l.
Sequence variations in the LTRs of retrovirus isolates are a common
phenomena and, in some cases, result in dramatic changes in the transcription factor
binding motifs discussed previously. Deletion, modification, or insertion of
recognition sites has been shown to affect in vitro promoter strength and replication
capacity of the virus (Carvalho et al., 1993). It has often been proposed that these
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sequence variations could influence the disease causing potential of different virus
isolates by influencing replication capacity or cellular tropism in vivo (Clements
and Payne, 1994).
The effects of LTR modification on virus phenotypes is well documented in
several oncovirus systems. Rous-associated virus (RAV) is a non-acute oncovirus
found in chickens. RAV-0 is benign whereas RAV-1 infection induces lymphoma
and a variety of neoplasms. By exchanging regions of a pathogenic proviral RAV1 clone with corresponding regions from RAV-0 proviral DNA, it was found that
the primary determinant of disease causing potential mapped to the 5' LTR region
(Brown et al., 1988). In a different study, investigators used the polymerase chain
reaction technique to amplify Feline leukemia virus proviral DNA from cats with
benign infections and from cats with thymic lymphomas. U3 sequences amplified
from tumor cells showed considerable sequence divergence from the parent strain
used for inoculation and 50% had sequence duplications of the core enhancer
region. A survey of U3 sequences from benign infections showed few differences
from the parental strain (Rohn and Overbaugh, 1995). Numerous experiments
performed with murine leukemia viruses indicate that their long terminal repeats
also confer tissue selectivity. Recombinant viruses with an LTR derived from a
virus which causes T-cell leukemia preferentially infected the thymus while the
same provirus backbone with an LTR derived from a virus which causes
erythroleukemia preferentially infected spleen and bone marrow (Rosen et al.,
1985). Of course, these examples all involve oncovirus systems in which the
primary pathological effect is cell transformation. Two mechanisms by which
oncoviruses induce transformation of the host cell, over-production of an adjacent
cellular gene or production of a viral oncogene, are directly dependent upon the
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promoter strength of the viral LTR. The affects of LTR variability on the behavior
of lentiviruses is more difficult to discern as diversity in structural or regulatory
gene products are most often responsible for changes in phenotype. In a study by
Englund et al. (1991), three HIV-1 molecular clones isolated from a single virus
stock demonstrated different replication kinetics and cytopathogenicity when
propagated in a human T-cell line. The molecular clone which produced reverse
transcriptase activity the most rapidly also caused the most rapid and severe loss of
host cell culture viability. The viral determinant for this behavior was subsequently
mapped to the LTR which was found to contain a 14 bp sequence insertion that
created a third NF-kB recognition motif. The basal promoter activity of this LTR
was subsequently found to be approximately four times as great as that of the LTRs
from the two remaining molecular clones. To demonstrate the influence of the
LTR on cellular or tissue tropism, transgenic mice were created which contained an
HIV-1 provirus under the control o f LTRs derived from infected neurons or from
infected T-cells. Mice containing LTRs derived from neurons showed viral
replication in their central nervous systems while mice containing T-cell tropic
LTRs did not (Corboy et al., 1992). Thus the LTR region of retroviruses can play a
very important role in tissue tropism which, in turn, can influence disease outcome.
Similar to other lentiviruses, the U3 region of the EIAV LTR demonstrates
a high degree of sequence variability. Analysis of viral cDNA isolated from
sequential disease episodes of a pony experimentally infected with a pathogenic
isolate of EIAV demonstrated a nucleotide divergence rate for the LTR as high as
5.6% compared to a 1.43% divergence overall. In addition, analysis of proviral
DNA isolated from horse peripheral blood mononuclear cell cultures (PBMCs)
infected in vitro yielded a similar result, a nucleotide divergence rate for the LTR as

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

34

high as 8.4% between two different virus stocks (Carpenter et al., 1991). Both
these studies also indicated that the majority of the sequence divergence was
localized to a hypervariable region centered approximately 60 bp upstream of the
TATA box which was prone to imperfect sequence duplications. These
duplications resulted in the insertion o f an additional 20 to 28 bp and the creation of
LTR sequence variants. These insertions may duplicate or create transcription
factor binding sites thereby changing the promoter activity of the LTR.
In a recent study, Carvalho et al (1993) examined the behavior of variant
LTR isolates, amplified from FEA cell cultures persistently infected with EIAV, in
U937, HeLa, and D17 cells. All these isolates contained sequence insertions in the
hypervariable region that created additional AP-1, Oct, and/or PU.l binding sites.
Transient expression assays demonstrated that the LTR variants behaved differently
from cell line to cell line. In U937 cells, the putative AP-1 duplication actually
seems to inhibit promoter activity while successive duplications of the PU.l motif
increase it. In HeLa cells, additional PU.l and/or AP-1 motifs result in increased
activity while neither duplication has any discernible effect on activity in D17 cells.
Only the creation of an Oct site results in an increase in basal promoter activity. It
was speculated that these LTR variations may influence disease outcome similar to
what occurs in other lentiviral systems.
Research Objectives
The goal of this dissertation research was to examine the influence o f EIAV
LTR variability on promoter activity, replication kinetics, cytopathogenicity, and
tissue tropism. The specific research objectives are: ( 1) isolation and sequence
analysis of multiple variant LTR isolates; (2) measurement of variant LTR
promoter strength by transient gene expression in cell cultures; (3) deletion analysis
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of the LTR variant exhibiting the highest promoter activity; (4) quantitation of
variant LTR sequences in DNA isolated from infected horse tissues using
competitive PCR; and (5) placement of an LTR variant in an infectious proviral
clone and examination of its replication kinetics and cytopathogenicity by
measurement of cell culture proliferation, reverse transcriptase activity, viral
mRNA and viral DNA production, and immunofluorescence.
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CHAPTER 2
MATERIALS AND METHODS
Virus Strains and Cell Cultures
Fetal donkey dermal (FDD), canine fetal thymic (Cf2th), and feline
embryonic (FEA) cell cultures were maintained in Eagle's minimum essential
media (MEM) (Sigma) supplemented with 10% fetal calf sera (Atlanta Biologicals)
and 50 ug/ml Gentamycin (Sigma). FDD-adapted EIAV (AFDD) was obtained by
sequential passage of Prototype virus in FDD cultures 27 times.
Preparation of Total Cellular DNA from Infected FDD Cultures
FDD cell cultures, infected with AFDD, were washed and harvested 6 days
post-infection with phosphate buffered saline (PBS) solution-10 mM EDTA
(PBSE). Cells were re-suspended in 10 mM Tris-HCl (pH. 8.0), 100 mM NaCl,
0.025 mM EDTA (pH 8.0), 0.1 mg/ml Proteinase K, 0.5% SDS, and incubated at
55°C overnight. The lysate was subjected to phenol and phenol/chloroform
extractions followed by ethanol precipitation and centrifugation. The pellet was resuspended in 50 mM Tris-HCl (pH 8.0), 10 mM MgCl2, 50 mM NaCl, 20 ug/ml
RNase A, and incubated at 37°C for one hour. The solution was extracted with
phenol/chloroform and ethanol precipitated sequentially in the presence of 2.5 M
NH4AC to remove free nucleotides. The air dried DNA pellet was re-suspended in
TE buffer (pH 7.6) at 50°C overnight and quantitated spectrophotometrically.
Amplification, Cloning, and Sequencing of AFDD LTR
The 3' LTR was amplified by the polymerase chain reaction using the
primer pair ->ALTR5 Y5'-ATTATGAAGCTTATGTATCAATGC CTCA-3 '1 and <ALTR3 '(5’-ATAATCCAGCTCTAGGATCTCGAACA-3') which contain the
restriction enzyme sites Hindlll and Pvull respectively. The amplification reaction
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was performed in 20 mM Tris-HCl (pH 8.8), 10 mM KCl, 10 mM (N H ^ S O ^
0.1% Triton X-100, 6 mM MgSC>4, 200 uM dNTPs, 2 uM primers, 0.5 ug template
DNA, and 2 units Vent (exo-) polymerase (New England Biolabs) at 94°C 1
minute, and 60°C 30 seconds for 35 cycles. The reaction product was digested with
Hindlll and Pviill restriction endonucleases and ligated into ///«dIII/£coRV
digested pBluescript II KS+ (Stratagene) to form pALTR/Blue constructs. Clones
were screened by sequencing using the dideoxy method as recommended by the
manufacturer (United States Biochemical). Sequence comparison and alignment
were performed using UWGCG software package. The sequence of AFDD LTR
clone 3 (ALTR3) was numbered relative to the putative transcription start site
previously identified for the LTR of EIAV molecular clone A.12 (Derse et al.,
1987).
Construction of LTR/Reporter Vectors
The pLTR/CAT expression vector, containing the 5' LTR of molecular
clone A.12 upstream of the chloramphenicol acetyl transferase (CAT) gene of
pSVO/CAT, was provided by Dr. Louis Schiltz. For purposes of clarity, this LTR
sequence will be referred to as Prtt and the construct pPrtt/CAT. Variant LTRs
from sequential horse isolates p3.2-l, p3.2-3, and p3.2-5 were obtained as
Sspl/Dral fragments of viral cDNA ligated into the multiple cloning region of
Hincll digested pUC13. These constructs were provided by Dr. Keith Rushlow.
The LTR variants were removed as HindllllMlul fragments and ligated with
MluUBamEl and BamW Hindlll vector fragments derived from pPrtt/CAT (Fig. 3).
The constructs produced (p3.2-1/CAT, p3.2-3/CAT, and p3.2-5/CAT) contain
variant U3 sequences upstream of the Mlul site, which includes the hypervariable
region, with the remainder of the LTR being identical to Prtt. ALTR3 and ALTR4
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Figure 3. Block diagram of the EIAV LTR. The relative locations of restriction
enzyme sites used in molecular cloning are indicated for the EIAV LTR in the
context of the pPrtt/CAT construct (Panel A) and the molecular clone pSPEIAV44
(Panel B).
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were removed and gel purified from pBluescript II KS+ and placed into
Hindlll/Stul digested pPrtt/CAT to form pALTR3/CAT and ALTR4/CAT. The
constructs contain variant sequences upstream of the Stul site. The cognate LTR
(PV44) of the infectious molecular clone pSPEIAV44 (Payne et al., 1994) was
obtained as an SpeVMlul fragment cloned into XbaUEcoRl digested pUC13. The
LTR was removed as a HindllUMlul fragment and ligated with MlullBamHI and
BamHUHindlll fragments of pPrtt/CAT to form pPV44/CAT. This construct
contains PV44 sequences upstream o f the Mlul site and Prtt sequences downstream.
Site-directed mutagenesis was used to create an Xhol site within the U3 region of
ALTR3. This facilitated the cloning of ALTR3 into an infectious EIAV clone. The
creation of A3(A7zoI)/Alt is outlined in another section. The LTR mutant was
removed from this construct as a HindllllHindlll fragment and placed into Hindlll
digested pSVO/CAT to form A3(A7?oI)/CAT. LTR fragments obtained by digestion
of pPrtt/CAT, pALTR3/CAT, p3.2-l/CAT, and p3.2-5/CAT with Hindlll were gel
purified and cloned into Hindlll digested pGL2-Enhancer (Promega) luciferase
reporter vector to generate pPrtt/Luc, pALTR3/Luc, p3.2-1/Luc, and p3.2-5/Luc.
All clones were verified by restriction digestion.
Deletion Mutagenesis of pPrtt/CAT
The LTR fragment that results from HindlHJAlul digestion of Prtt,
containing U5, R, and U3 sequences downstream of the Alul site, was modified
with a synthetic Mndlll linker and subsequently inserted into Hindlll digested
pSVO/CAT to form pD(//mdIIIA4M)/CAT. A construct which contains no U3
sequences upstream of the Alul site. The deletion mutant pD(zl/wI///z>jcII)/CAT
was created by joining a PstUAlul fragment, containing the first 94 base pairs of
U3, to a HinclUEcoRl fragment, containing U5, R, some U3 sequences, and a
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portion of the CAT gene, which had been inserted into Hincll/EcoRl digested
pUC13. The LTR sequences were removed from this intermediate as a Hindlll
fragment and inserted into Hindlll digested pSVO/CAT. This construct is missing
the hypervariable region and flanking sequences. Products were screened by
restriction enzyme digestion and verified by sequencing.
Construction of ALTR3/Luc Mutants.
Deletion mutants were derived from pALTR3/Blue using a primer directed
method. In brief, this procedure uses a pair of primers, which flank the region to be
deleted, to amplify the remainder of the LTR and the entire vector to produce a
linear molecule which is subsequently re-ligated and propagated within a bacteria
host. Reactions were performed in 20 mM Tris-HCl, 10 mM KCI, 10 mM
(NH4)2SC>4, 0.1% Triton X-100, 6 mM MgS0 4, 200 uM dNTPs, 1-2 uM primers,
2 ng template DNA (pLTR3/Blue), and 2 units Vent (exo+) polymerase at 94°C 2
minutes, 62°C 1 minute, and 72°C 3 minutes for 25 cycles. Products were screened
by sequencing and correct mutant LTR sequences were excised from pBluescript II
KS+ with Kpril/Sacl and inserted into the pGL2-Enhancer vector similarly digested.
Primer pairs used and their deletion products are described in Table 2.
Transfection of FDD Cell Cultures
Transfections were performed using the calcium phosphate precipitation
technique. All plasmid DNA was purified by large scale alkaline lysis followed by
centrifugation in CsCl/ethidium bromide density gradients. Ethidium bromide and
cesium chloride were removed by four butanol extractions and two ethanol
precipitations respectively. Purified DNA was quantitated spectrophotometrically.
FDD, Cf2th, and FEA cells were plated at a density of approximately 2x 10^ cells
per well in 6 well (35 mm) culture dishes and allowed to grow for 24 hours. Cells
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were washed once with serum-free MEM media and re-fed with 3 mis fresh growth
media prior to transfection. A 0.250 M CaCl2 solution (0.150 ml) was mixed with
3 ug LTR reporter vector, 6 ug pSV/p-Gal (Promega), and I ug pBluescript DNA
in the case of basal conditions or 3 ug LTR reporter vector, 6 ug pSV/p-Gal, and 1
ug pSV/720 DNA (an EIAV Tat expression plasmid) in the case of transactivated
conditions. A 280 mM NaCl, 50 mM HEPES, and 1.5 mM Na2HP0 4 -7H20
solution (HBS) (pH 7.1) (0.150 ml) was added drop-wise under a stream of
nitrogen gas. The solution was incubated at room temperature for 15 minutes and
then added drop-wise to the appropriate tissue culture well. Transfection was
allowed to proceed for 6 hours followed by a serum free media wash, a 3 minute
glycerol shock (15%), a serum free media wash, followed by the addition of 3 mis
of growth media. Cells were harvested for CAT assay 48 hours post-transfection
by washing and harvesting in PBSE followed by one wash in regular PBS.

Table 2. Primer pairs and their deletion products.
Primer Pair

Deletion Construct

<—LTRP1: 5'-CATACTGAGGCATT GATAC AT-31
-*LTRP2: 5’-AAATGATTATAAGAGTAAAAAGAA-3'

pD(-233/-185)/Luc

<—LTRP3: 5'-TTTATAAAACCCCTCATAAAAAC-3'
->LTRP4: 5'-ATAACCCAAAGGACTAGCTCA-3'

pD(-181/-135)/Luc

<-LTRP5: 5'-AGGTTATGAGAGCATCAGCAA-3'
->LTRP6: 5'-CTCATGTTGCTAGGCAACTAA-3'

pD(-137/-118)/Luc

<—LTRP7: 5'-CTAGTCCTTTGGGTTATGCA-3'
—>LTRP8: 5-CTAAACCGCAATAACCGCAT-3'

pD(-117/-101)/Luc
table con’d
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4-LTRP9: 5'-GTTAGTTGCCTAGCAACATGA-3'
->LTRP10: 5'-CCGCATTTGTGACGCGAGTT-3'

pD(-94/-87)/Luc

<—LTRP11: 5'-GTTATTGCGGTTTAGTTGCCAT-3'
-»LTRP12: 5'-TGTGACGCGAGTTCCACATTT-3'

pD(-85/-80)Luc

<-LTRP13: 5'-CAAATGCGGTTATTGCGGTT-3'
-+LTRP14: 5'-TTGTGACGCATTTAACTTCCT-31

pD(-77/-61)Luc

<-LTRP15: 5'-CAAATGTGGAACTCGCGTCA-3'
-»LTRP16: 5'-CCTGTTTTTACAGTATATAAGTG-3'

pD(-57/-43)Luc

<—LTRP17: 5'-TAAATGCGTCACAAATGTGGAA-3'
-»LTRP18: 5'-GTATATAAGTGCTTGTATTCTGA-3'

pD(-46/-31)Luc

<-LTRP19: 5’-CCGATTGTCAGAATACAAGCA-3'
->LTRP20: S'-CTTCTCTGCTGGGCTGAAA^’

pD(l/26)Luc

<-LTRP21: 5-AGAAGGGACTCAGACCGCA-3'
-►LTRP22: 5'-GTTTGTCTGTTCGAGATCCTA-3'

pD(32/90)Luc

Chloramphenicol Acetyl Transferase and Luciferase Enzyme Assays
CAT assays were performed by the acetyl-chloramphenicol diffusion
method (Neuman et al., 1987). Cell pellets were re-suspended in 100 mM Tris
buffer (pH 7.8) and subjected to three rounds of rapid freeze-thawing in a dry ice,
ethanol bath. Insoluble cellular debris was pelleted by centrifugation (12,500xg) at
4°C for 5 minutes. The supernatant (0.050 ml) was heated to 70°C for 15 minutes,
mixed with 0.200 ml o f a 1.25 mM chloramphenicol (Sigma), 100 mM Tris (pH
7.8) and 0.02 uCi [^ C ] butyryl coenzyme A (Dupont-NEN) solution. This
solution was transferred to a 7 ml liquid scintillation counting (LSC) vial, overlaid
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with 5 ml Econofluor LSC fluid (Dupont), and counted in a Beckman LSC 6000
after 16 hours at 37°C. Values represent CPM per uU P-galactosidase and an
average of at least three trials. Luciferase assays were performed as recommended
by the manufacturer. FDD cell pellets were re-suspended in 0.200 ml reporter lysis
buffer and subjected to two rounds o f rapid freeze-thaw. Cellular debris was
removed by centrifugation (12,500xg) at 4°C for 5 minutes. The supernatant
(0.005 ml) was diluted to 0.020 ml with reporter lysis buffer, mixed with 0.100 ml
luciferase assay reagent, incubated 1 minute, and counted in a Beckman LSC 4000
in single photon counting mode. Values represent CPM per nU P-galactosidase and
an average of at least three trials. P-galactosidase activity was measured by mixing
0.015 ml of cell lysate with 0.300 ml o f a 100 mM sodium phosphate (pH 7.5), 1
mM MgCl2, 45 mM p-mercaptoethanol, and 2.2 mg/ml o-nitrophenyl-P-Dgalactopyranoside solution at 37°C for 16 hours and measured by
spectrophotometric quantitation at 420 nm as outlined in Sambrook et al. (1989).
All mean values were analyzed for statistical significance using the Kruskal-Wallis
one way analysis of variance based on ranks and Dunnetts method of pairwise
comparison.
Insertion of ALTR3 into an Infectious Clone
The LTR regions of the infectious proviral clone pSPEIAV44 and AFDD3
were separately inserted into the mutagenesis vector pALTER-1 (Promega). The
proviral LTR was removed as an NruUBambO. fragment, which contains the entire
3' LTR and part of the env gene, and inserted into SmallBamHl digested pALTER1 to form pPV44/Alt (Fig. 3). Likewise, ALTR3 was removed from pALTR3/CAT
as a Hindlll fragment and inserted into the Hindlll site of pALTER-1 to create
pALTR3/Alt. Both were subsequently subjected to site-directed mutagenesis using
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the pALTER system (Promega) in order to create an ATjoI site within the U3 region
upstream of the hypervariable region. Template DNA (pPV44/Alt or pALTR3/Alt)
was denatured by incubation in a 2 M NaOH, 2 mM EDTA solution for 5 minutes
at room temperature followed by ethanol precipitation. The denatured template
DNA (0.05 pmole) was incubated with 1.25 pmol mutagenic oligonucleotide
LTRMOD+ (5'-TGCTGATGCTCGAGTAACCTTGTAT-3’) and 0.25 pmole
ampicillin repair oligonucleotide (supplied by the manufacturer), in 20 mM TrisHC1 (pH 7.5), 10 mM MgCl2, and 50 mM NaCl at 70°C for 5 minutes and allowed
to cool slowly to room temperature. This solution was then adjusted to contain 0.5
mM dNTPs, 1 mM ATP, 2 mM DTT, 10 units T4 DNA polymerase, and 2 units T4
DNA ligase followed by incubation at 37°C for 90 minutes. The reaction was
cooled and used to transform competent ES1301 mutS Eschericia Coli cells.
Transformed ES1301 culture was incubated overnight in LB media/125 ug/ml
ampicillin/10 ug/ml tetracycline. Plasmid DNA isolated from the overnight
ESI301 culture was used to transform competent JM109 bacteria cells which were
subsequently plated on LB/125 ug/ml ampicillin/10 ug/ml tetracycline. Clones
were screened by restriction digestion and sequencing. A mutated clone,
pA3(A7zoI)/Alt, was digested with XhoVStul and the LTR fragment was inserted
into Xhol/Stul digested pPV44(A7zoI)/Alt to form pPVA3/Alt. Spel and Sail were
used to remove the pPVA3/Alt envfLTR fragment which was then inserted into
SpeUSall digested pSPEIAV44 to create pSPEIAVAd3.
Production and Propagation of Virus Strains
Approximately 2x10^ feline embryonic cells (FEA) were transfected with
10 ug of pSPELAV44 or pSPEIAVAd3 DNA according to the calcium phosphate
procedure discussed elsewhere. Transfected cell cultures were propagated for two
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weeks in MEM/10% FCS/50 ug/ml gentamycin after transfer to 150 cm^ flasks.
Cell culture supernatants were then stored at -70°C and used as infectious virus
stocks in subsequent studies of viral replication kinetics and cytopathogenicity.
Virus stocks were titered for infectivity by the end-point dilution technique. The
end-point dilution technique involves exposing fresh cell monolayers to increasing
dilutions of the infectious virus stock. At some point, the virus stock will be so
diluted as to be rendered no longer infectious. After several weeks of incubation,
the cell monolayers are assayed for production of viral antigen which indicates
infection. The greatest dilution which still renders infection is considered to
contain one infectious unit. With this information, the number of infectious units
per ml for the original stock can be calculated. Five-fold dilutions of the virus
stocks (lx l0 '3 to 3x 10"6) in a volume of 1 ml were incubated with 1x10^ FDD
cells at 37°C for two hours. Cells were washed 3 times with PBS and then re-fed
with MEM/5% FCS/50 ug/ml gentamycin and propagated for 18 days. Cell culture
supernatants were subsequently assayed for viral antigen by ELISA assay. This
procedure was run in triplicate for each virus stock allowing an average titer to be
determined. The final titers for pSPEIAV44, pSPEIAVAd3, and AFDD were 10^,
lO^-?, and 10^-4 infectious units per ml respectively.
ELISA assays for viral antigen
Cell culture supernatants (0.100 ml) were added to a standard 96 well
ELISA plate containing 0.020 ml 1% Triton per well and incubated at room
temperature for 1 hour with agitation. This treatment lysed the virus and allowed
the viral proteins to attach to the plate. Wells were washed 3 times with
PBS/0.05% Tween 20 (PBST)and blocked with 0.300 mis PBS/0.05% tween
20/5% instant milk (Blotto) for 30 minutes. After washing as stated above, plates
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were dried for fifteen minutes at 37°C to irreversibly bind viral antigen and
blocking protein to the plate. Anti-p26 rabbit polyclonal antiserum (0.100 ml at a
1/500 dilution in blotto) was added to wells for 1 hour. Plates were subsequently
washed and incubated 1 hour with 0.100 mis of anti-rabbit peroxidase conjugated
antiserum (1/1000 dilution in blotto). After washing, the plates were assayed for
peroxidase activity as stated by the manufacturer by incubation with 0.1 mg/ml
tetramethylbenzidine dihydrochloride, and 0.006% hydrogen peroxide in
phosphate-citrate buffer (pH 5.0) for 30 minutes at room temperature followed by
spectrophotometric quantitation at 655 nm.
Time-course Infection of FDD Cell Cultures
Approximately 1x10^ FDD cells at 50% to 70% confluency were incubated
with AFDD, pSPEIAV44, or pSPEIAVAd3 virus cultures at a multiplicity of
infection of 0.1 at 37°C for 1 hour. Cells were washed three times with PBS, split
into six 6-well tissue culture plates (35 mm) and propagated in MEM/5% FCS/50
ug/ml gentamycin. Every 24 hours, wells were harvested for Northern and
Southern blot analysis with the growth media saved for measurement of soluble
reverse transcriptase activity and the viability of the cell culture was measured.
Remaining wells were washed three times with PBS and re-fed.
Determination of Cell Culture Viability
The viability of the infected cell cultures as well as a mock-infected control
culture was determined daily using a Cell Titer 96 AQueous Non-Radioactive Cell
Proliferation Assay Kit (Promega) according to the manufacturers directions. This
colorimetric procedure measures the reduction of a tetrazolium compound into a
soluble formazan product by cellular dehydrogenase enzymes. The soluble
formazan is subsequently released into the culture supernatant and can be
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quantitated at 490 nm. This procedure measures the overall metabolic rate of the
cell culture which is dependent upon the number o f viable cells and their rate of
growth. Assuming similar rates of growth, absorbance measurements obtained
from infected cell cultures were compared to a standard curve, which plots
absorbance versus cell number (as determined by standard trypan blue exclusion),
for an uninfected control culture, in order to obtain the cell titer for the infected cell
culture. Specific experimental conditions were as follows. Cell monolayers were
washed and overlaid with 1 ml fresh growth media to which 0.200 ml of a
MTS/PMS (3-(4,5-dimethyithiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4sulfophenyl)-2H-tetrazolium salt and phenazine methosulfate respectively) solution
was added. Cultures were allowed to incubate at 37°C for 4 hours after which the
media was quantitated at 490 nm.
Reverse Transcriptase Analysis
One o f the most accurate methods to quantitate retrovirus infections is by
measuring reverse transcriptase activity. Virus was precipitated from cell culture
supernatants by the addition o f 0.250 ml of a 40% polyethylene glycol solution and
incubation overnight at 4°C with gentle agitation. This solution was then spun at
12,500xg at 4°C for 15 minutes to pellet the virus. After complete removal of the
supernatant, the virus pellet was lysed by re-suspension in 0.040 ml of solubilizing
buffer (50 mM Tris (pH 7.8), 20% glycerol, 0.8 M NaCl, 0.5% Triton X-100, and
0.5 mM phenylmethylsulfonylfluoride) and incubated on ice for 10 minutes.
Solubilized virus (0.020 ml) was added to 0.180 ml of reaction buffer (52 mM Tris
(pH 7.8), 10 mM MgCl, 5 mM DTT, 0.20 mM dATP, 0.9 ug poly(rA)-oligo(dT),
and 52 uCi [^HjdTTP) and incubated at 37°C for 1 hour. Yeast tRNA was added to
a final concentration of 0.1 mg/ml followed by 1 ml of ice cold 10% trichloroacetic
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acid in order to precipitate nucleic acid. The solution was kept on ice for 30
minutes followed by filtration through a grade 25 glass microfiber filter. Filters
were then washed three times with 1 ml of ice cold 5% TCA, 1 ml 70% ice cold
ethanol, and 1 ml ether. Dried filters were counted in 7 mis Liquiscint liquid
scintillation cocktail in a Beckman LSC 6000 for 1 minute. Final values reflect
subtraction of background counts.
Isolation and Purification of Poly-adenylated RNA
Cell cultures were harvested by incubation in PBSE for 10 minutes at 37°C
followed by three washes in PBS. Cell pellets were re-suspended in 0.400 ml
denaturing solution (4 M guanidinium thiocyanate, 25 mM sodium citrate (pH 7),
0.5% sodium sarcosyl, and 0.1 M 2-mercaptoethanol) and incubated on ice for 10
minutes. Sequentially, 0.04 ml sodium acetate (pH 5.2) and 1 ml phenol (pH
4.0)/chloroform/isoamyl alcohol (25/24/1) were added and the solution incubated
on ice for 30 minutes followed by centrifugation at 12,500xg for 15 minutes at 4°C.
RNA was precipitated from the aqueous solution and washed in 70% ethanol.
Poly-adenylated (Poly-A) RNA was purified from the total RNA by using a MicroFastTrack mRNA isolation kit (Invitrogen) and quantitated.
Isolation and Purification of DNA
Cell cultures were harvested by incubation in PBSE for 10 minutes at 37°
followed by three washes in PBS. Cells were re-suspended in 10 mM Tris-HCl
(pH. 8.0), 100 mM NaCl, 0.025 mM EDTA (pH 8.0), 0.1 mg/ml Proteinase K,
0.5% SDS, and incubated at 55^C overnight. The lysate was subjected to phenol
and phenol/chloroform extractions followed by ethanol precipitation and
centrifugation. The pellet was re-suspended in 50 mM Tris-HCl (pH 8.0), 10 mM
MgCl2, 50 mM NaCl, 20 ug/ml RNase A, and incubated at 37°C for one hour. The
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solution was extracted with phenol/chloroform and ethanol precipitated
sequentially in the presence of 2.5 M NH4AC to remove free nucleotides. The air
dried DNA pellet was re-suspended in TE buffer (pH 7.6) at 50°C overnight and
quantitated.
Northern Blot Analysis
Sequentially, 0.6 ug poly-A RNA was re-suspended in 40 mM MOPS (pH
7.0), 10 mM sodium acetate, 0.2 mM EDTA, 50% formamide, and 6%
formaldehyde, incubated at 60°C for 15 minutes, and allowed to cool on ice.
Glycerol, xylene cyanol, and bromophenol blue were added to final concentrations
of 10%, 0.08%, and 0.08% respectively. Samples were applied to a 1.5% agarose
gel that contained 6% formaldehyde. Electrophoresis was conducted in 40 mM
MOPS (pH 7.0), 10 mM sodium acetate, 0.2 mM EDTA at 25 volts for 4.5 hours.
Upon completion of electrophoresis, the gel was washed in lxSSC (0.15 M sodium
chloride, 0.015 sodium citrate) and the RNA transferred to a Nytran membrane
(Schleicher and Schuell) by the capillary method in lOxSSC overnight. The
membrane was washed in 5xSSC for 5 minutes and then cross-linked by exposure
to 120 mJ/cm^ of UV light in a Stratagene Stratalinker. The blot was pre
hybridized in 50% formamide, 5xSSC, 0.1% SDS, 200 pg/ml sonicated herring
sperm DNA, and 5xDenhardt's reagent at 42°C for 2 hours followed by
hybridization, in fresh pre-hybridization solution plus approximately 10 ng/ml
denatured probe (1x10^ CPM/ml), overnight at 42°C. Probe prepared using a
Rediprime DNA labeling system (Amersham) with pSPEIAV44 as the template
DNA and Redivue [32p]dCTP (Amersham). Washes were performed twice in 6x
SSC, 0.5% SDS at room temperature for 15 minutes, twice in lxSSC, 0.5% SDS at
37°C for 15 minutes, once in O.lxSSC, 0.1% SDS at 65°C for 30 minutes, and once
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in O.lxSSC at room temperature for 15 minutes. The damp membrane was inserted
between two plastic transparency sheets and exposed to X-OMAT AR (Kodak) Xray film for 24 to 48 hours.
Southern Blot Analysis
Cellular DNA (5.0 ug) was digested to completion with Stul, which cuts the
EIAV genome in the LTR U5 region exclusively. Glycerol, xylene cyanol, and
bromophenol blue were added to final concentrations o f 10%, 0.08%, and 0.08%
respectively and the sample was subjected to electrophoresis in a 0.8% agarose gel
in TAE for 16 hours at 20 volts. Upon completion of electrophoresis, the gel was
soaked once in 0.25 M HC1 for 10 minutes, twice in 1.0 M NaCl, 0.5 M NaOH for
15 minutes, and twice in 1.5 M NaCl, 0.5 M Tris (pH 7.4). The fractionated DNA
was then transferred to a Nytran membrane (Schleicher and Schuell) by the
capillary method in lOxSSC overnight. The membrane was washed in 5xSSC for 5
minutes and then cross-linked by exposure to 120 mJ/cm^ of UV light in a
Stratagene Stratalinker. The blot was pre-hybridized in 50% formamide, 6xSSC,
0.5% SDS, 200 ug/ml sonicated herring sperm DNA, and 5xDenhardt's reagent at
42°C for 2 hours followed by hybridization, in fresh pre-hybridization solution plus
approximately 10 ng/ml denatured probe (1x10? CPM/ml), overnight at 42°C.
Probe prepared using a Rediprime DNA labeling system (Amersham) with
pSPEIAV44 as the template DNA and Redivue [32p]dCTP (Amersham). Washes
were performed twice in 7xSSC, 0.5% SDS at room temperature for 15 minutes,
twice in lxSSC, 0.5% SDS at 37°C for 15 minutes, once in O.lxSSC, 0.5% SDS at
65°C for 30 minutes, and once in O.lxSSC at room temperature for 15 minutes.
The damp membrane was inserted between two plastic transparency sheets and
exposed to X-OMAT AR (Kodak) X-ray film for 72 hours.
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Immunofluorescent Slide Staining
Cell monolayers were washed once in PBS and harvested in 1 ml PBSE.
Cell suspensions were streaked onto gelatin coated slides and allowed to air dry.
Cell smears were fixed by incubation in acetone/formaldehyde fixing solution for
30 seconds at room temperature and air dried. Fixed slides were incubated in
blocking solution (PBS with 5% BSA) for 1 hour followed by incubation in PBS
plus rabbit polyclonal antiserum against EIAV protein gp90 (1/50 dilution) for 2
hours. Smears were washed for 10 minutes in PBS/tween 20 (0.5%) 3 times and reblocked in PBS/BSA for 1 hour followed by incubation with anti-rabbit fluorescein
conjugate diluted 1/100 in PBS for 2 hours. All of these steps were performed at 4°
C. Following final washing (3 times in PBS/tween 20), ceils were photographed
using a fluorescent light source at 400x magnification.
Competitive PCR
Reactions were performed primarily by Pramod Vijayagopal of Dr. Ding
Shih's laboratory using horse tissue genomic DNA kindly provided by Dr. Susan
Payne. Genomic DNA was isolated from liver, lung, kidney, and lymph node
tissues of a horse euthanized during an acute disease episode after being
experimentally infected with the Wyoming strain of EIAV. Samples were isolated
and purified by Dr. Payne using Qiagen DNA purification columns according to the
manufacturers directions and supplied to this investigator in a lyophilized form.
The control plasmids, pDl/GL2 and pD3/GL2, were constructed from LTR variants
p3.2-l and p3.2-3 which were removed from pSVO as Hindlll fragments and cloned
into the tfmdlll site of pGL2-Enhancer. Deletion of 58 bp from the U5 regions of
these LTRs was accomplished using the primer directed method outlined elsewhere
and the primer pair <-LTRP21 (5-AGAAGGGACTCAGACCGCA-3') and —»
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LTRP22 (5'-GTTTGTCTGTTCGAGATCCTA-3') which delete LTR sequences
between nucleotides 32 and 90. This deletion allows control plasmid amplification
products to be separated from tissue DNA products electrophoretically. The
oligonucleotide primer -»P-3 (5’-TAAAATGTAGTTCCTCAATATAGTTCCG-3')
is identical to a unique region (nucleotides -111 to -84) of variant LTR 3.2-3 and
will only amplify similar LTR variants. Primer -»P-1 (5ATTTGTGACGCGAGTTCCCCATTGG-31) is identical to a unique region
(nucleotides -84 to -58)of variant LTR 3.2-1 and will only amplify similar variants.
The primer <-P-C (5'-GTAGGATCTCGAACAGACAAAC-3') is complementary
to a region at the end of the LTR (nucleotides 112 to 91) and will recognize both
types of LTR variants. Reactions were performed in 20 mM Tris-HCl, 10 mM
KC1,10 mM (NH4)2S 04, 0.1% Triton X-100, 6 mM MgS04, 200 uM dNTPs, 200
uM [a-35s]dATP, 1 uM primers (-»P-1 and <—P-C or —>P-3 and «-P-C), 150 ng
infected tissue DNA (liver, lymph node, lung, or kidney), 300 to 0.003 pg control
plasmid DNA (pDl/GL2 or pD3/GL2), and 2 units Taq polymerase at 94°C (60
seconds) and 60°C (30 seconds) for 35 cycles. Reactions were resolved on 8%
non-denaturing polyacrylamide gels in lxTBE at 50 volts for 5 hours. Gels were
fixed in 7% acetic acid for 20 minutes followed by vacuum drying and exposure to
X-omat AR film for 24 hours at room temperature.
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CHAPTER 3
RESULTS AND DISCUSSION
Comparative Analysis of Variant LTR Sequences
The prototype LTR, Prtt, was obtained from a proviral DNA clone o f EIAV,
XI2. (Rasty et a l, 1990). It contains a number of possible transcription factor
binding sites including a PU.l an AP-1, and two PEA2 motifs. These sites have
been identified using a variety of established cell lines such as human monocytic
(U937), cervical carcinoma (Hela), canine osteosarcoma (D17), and equine
fibroblasts (equine 6288), as well as primary horse macrophage cultures (Carvalho
and Derse, 1993a; Carvalho and Derse, 1993b; Carvalho et al., 1993; Maury,
1994). Although the EIAV LTR may form unique transcription factor complexes
within each different cell type, these motifs influence promoter activity in some
manner in almost every cell culture in which the LTR has been studied. Therefore,
it is likely that some of these same motifs influence the promoter activity of the
LTR within FDD, Cf2Th, and FEA cells as well.
Sequence variations within the EIAV LTR that result in duplication or
modification of these sites is well documented. These variations can influence the
promoter strength of the LTR in a cell-line dependent manner (Carpenter et al.,
1991; Carvalho et al, 1993) and it has been suggested that they may play a role in
influencing cellular tropism of the virus in vivo. In addition, the LTR directly
influences the quantity of viral mRNA, the levels of which, in turn, influence the
replication kinetics or replication capacity of the virus. While a higher replication
rate may result in a more virulent sub-type of virus, increasing the severity of
disease episodes, a lower relative rate of replication, resulting in attenuation, may
cause the virus to establish less severe, persistent infections. Due to the lack of a
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pathogenic molecular clone, this study relied primarily on in vitro experiments,
examining the effects of LTR variation on promoter strength, replication, and
cytopathogenicity, in order to implicate LTR sequence variation in virus pathology.
The first step of this investigation involved the sequence analysis of
multiple LTR variants from a variety of sources. ALTR3 and ALTR4 were
amplified from the cellular DNA o f FDD cell cultures infected with FDD-adapted
virus (AFDD), a virus stock that demonstrates accelerated cytopathogenic effects in
FDD cell cultures, using the polymerase chain reaction. Six of the positive clones
identified were sequenced and their homology analyzed by the software program
Pileup (Genetics Computer Group). This program generates an alignment of
multiple DNA sequences representing their maximum homology. The six AFDD
LTR sequences analyzed were highly homologous with a maximum variability of
only 1.6 percent. AFDD LTR clone 3, ALTR3, and clone 4, ALTR4, were chosen
for subsequent functional studies as they represent the majority of LTR sequence
variants within the AFDD strain. These sequences were aligned and compared with
Prtt (Fig. 4). Alignments were based on maximum sequence homology and
numbered relative to the ALTR3 sequence. The hypervariable region of ALTR3
differs from the corresponding Prtt region in that it contains a 20 bp sequence
insertion, upstream of the putative transcription start site of ALTR3 beginning at
position -58, as well as an additional adenine residue at position -51. ALTR3 also
contains three transitions relative to Prtt; a thymine to cytosine at -135, an adenine
to guanine at -164, and a thymine to cytosine at position -3. These mutations may
have a significant effect on transcription factor binding sites or regulatory elements
previously identified in the prototype LTR. The large sequence insertion causes
imperfect duplications of the putative PU.l and AP-1 binding sites and the
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Figure 4. Sequence comparison of variant LTR isolates. Alignment of LTR
variants isolated from FDD-adapted virus, (ALTR3 and ALTR4), molecular clone
X12 (Prtt), molecular clone pSPELAV44 (PV44), and three sequential isolates from
an infected pony (p3.2-l, p3.2-3, and p3.2-5). Alignments were based on
maximum sequence homology and numbered relative to the transcription start site
of ALTR3. Transcription factor recognition sites, TATA box, and TAR element,
are also shown.
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-210
ALTR3:
ALTR4:
3.2-1:
Prtt:
PV44:
3.2-3:
3.2-5:

ALTR3:
ALTR4:
32-1:
Prtt:
PV44:
3.2-3:
3.2-5:

ALTR3:
ALTR4:
3.2-1:
Prtt:

TGTGGGGTTT TTATGAGGGG TTTTATAAAT GATTATAAGA GTAAAAGGAA
A
A
A
A
A
A
-160
AGTTGCTGAT GCTCTCATAA CCTTGCATAA CCCAAAGGAC TAGCTCATGT
T
T
T
T
T
T
_________________ PEA2_________________
-HO
PEA2
TGCTAGGCAA CTAAACCGCA ATAA----------------------------------------------- CCGCAT

PV44:
3.2-3:
3.2-5:

A

PU.l
PU.l
ATGCAGTTTC TCAATATAGT T
AATGTAGTTTC TCAATATAGT T
ACTGAGTTCC TCAATATAGT T

-80
AP-1
PU.l
AP-1
PU.l
ALTR3:
TTGTGACGCG AGTTCCACAT TTGTGACGCA TTTAACTTCC TGTTTTTACA
ALTR4:
—
3.2-1:
C
G
—G
P
r t t : ------------------------------------------------------------- G
PV44:
-------------------------------------------- G
3.2-3:
------------------------------------------------------------- G
3.2-5:------------------------TA---------------------------- ----------------- G

ALTR3:
ALTR4:
3.2-1:
Prtt:
PV44:
3.2-3:
3.2-5:

-30
+J___________ TAR__________
GTATATAAGT GCTTGTATTC TGACAATCGG GCACTCAGAT TCTGCGGTCT
T
T
T
T
T
21______

ALTR3:

GAGTCCCTTC TCTGCTGGGC TGAAAAGGCC TTTGTAATAA ATATAATTCT

71
ALTR3: CTACTCAGTC CCTGTCTCTA GTTTGTCTGT TCGAGATCCT AC A
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additional adenine at position -51 brings the original AP-1 site closer to a
consensus recognition sequence (TGASTMA) (Carvalho and Derse, 1993a;
Carvalho and Derse, 1993b; Diamond et al., 1990; Maury, 1994). ALTR4 is very
similar to ALTR3 except it retains an adenine residue at position -164, a thymine at
position -135, and is missing three thymine residues at positions -79 to -81. Based
on sequence analysis, the AFDD LTR contains a number of mutations that could
create additional transcription factor binding sites or modify pre-existing ones.
The cognate LTR, PV44, of pSPEIAV44, an infectious molecular clone of
EIAV produced from the virulent cell culture stock PV (Payne et al., 1994), was
also compared to the Prtt, ALTR3, and ALTR4 sequences. It contains an insertion
of 21 bp, relative to Prtt, within the hypervariable region but this insertion causes
the formation of a possible PU.l site without the creation of a new AP-1 site as
seen in AFDD LTR sequences. The insertion also interrupts one of the putative
PEA2 sites (GACCGCA) (Carvalho and Derse, 1993a).
Additional variants, 3.2-1, 3.2-3, and 3.2-5 were isolated during sequential
disease episodes experienced by an experimentally infected pony (Payne et al.,
1987). Although derived from the same host, variant 3.2-1 is more homologous to
ALTR3 and ALTR4 while variants 3.2-3 and 3.2-4 are more homologous to PV44.
Isolate 3.2-1 contains a 20 bp insertion/duplication almost identical to that of
ALTR3 and ALTR4 with the exception of adenine to cytosine and thymine to
guanine base pair transitions at positions -74 and -59 respectively. With the
exception of the insertion, 3.2-1 is identical to Prtt. Therefore, like ALTR3 and
ALTR4, it contains imperfect duplications of the putative AP-1 and PU.l binding
sites but, like Prtt, its original AP-1 site is less homologous to the consensus
recognition sequence. Variant 3.2-3 contains an insertion almost identical to that of
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PV44 with the exceptions of an additional adenine residue at the beginning and a
cytosine to thymine transition 4 bp downstream of the additional adenine. Neither
of these mutations would create or interfere with any of the recognition motifs
identified in the discussion of PV44. Other than the insertion, 3.2-3 is identical to
Prtt. Variant 3.2-5 is a very unique variant in that it contains two significant
insertions. It contains a 21 bp insertion between positions -86 and -87 which is
very similar to that of PV44 with one significant exception. A thymine to cytosine
transition 9 nucleotides into the insertion creates a second possible PU. 1
recognition motif. The transition restores the TTCC core binding motif found in
the original PU.l site. In addition, 3.2-5 contains 5 bp identical to nucleotides -78
to -74 of ALTR3 followed by additional thymine and adenine nucleotides. The
remainder of variant 3.2-5 is identical to Prtt. Therefore, variant 3.2-5 may contain
up to three PU.l and two AP-1 binding sites in close proximity to the TATA box.
In order to facilitate the cloning of ALTR3 into the proviral clone
pSPEIAV44, an ATroI site was produced by site-directed mutagenesis in a region
believed to be devoid of any transcription factor binding motifs. A3(Xhol) was
included in subsequent transient gene expression studies to verify that this mutation
had no effect on the promoter strength of the LTR.
As can be seen by these comparisons, the EIAV LTR shows considerable
heterogeneity even when isolated from the same host. The greatest region of
disparity is centered approximately 70 nucleotides upstream of the TATA box. It is
interesting to note that LTR variants, despite the source, can be separated into two
broad classes based upon their sequence homology and transcription factor motifs.
Those that contain two PEA2, AP-1, and PU.l sites such as ALTR3, ALTR4, and
3.2-1 and those that contain only one PEA2 and AP-l but three possible PU. 1
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binding sites such as 3.2-3,3.2-5, and PV44. O f course, this is a very loose
classification as small mutations can destroy possible binding sites such as the third
PU.l site or create additional AP-1 sites as seen in variants PV44,3.2-3, and 3.2-5
respectively. The Prtt LTR, which is the shortest functional LTR isolated to date,
would fall into neither category.
Relative Promoter Strength of Variant LTR Sequences
To assess the impact of sequence variation within the AFDD LTR on its
promoter strength, transient gene expression assays were performed using FDD,
Cf2Th, and FEA cell cultures. Variant LTR sequences ALTR3, ALTR4,
A3(Xhol), 3.2-1, Prtt, PV44, 3.2-3 and 3.2-5 were placed upstream of the
chloramphenicol acetyl transferase, CAT, gene o f pSVO/CAT (Gorman et al., 1982)
and transfected into cells by the calcium phosphate precipitation technique. Values
represent the mean of at least six trials, normalized with P-galactosidase activity,
with standard error and statistical significance as indicated (Table 3).
In FDD cell cultures, variant 3.2-5 was the least active promoter under basal
conditions. Despite their slightly higher activity, Prtt, PV44, and 3.2-3 did not
behave significantly different from 3.2-5 while ALTR3, ALTR4, A3(Xhol), and
3.2-1 were 5 to 9 times as active. The high activity of ALTR3, ALTR4, A3(Xhol),
and 3.2-1 relative to the remainder of the variants indicates that the duplicated AP-1
motif, common only to these four variants, or an unidentified overlapping motif is
responsible for the increase in promoter strength. Although these four variants also
share a duplicated PU.l site, it seems unlikely that this motif is responsible for their
increased promoter strength as PV44, 3.2-3 and 3.2-5 also contain duplicated PU.l
motifs. Variant 3.2-5 contains an additional possible AP-1 site, but it is less
homologous to the consensus recognition sequence and appears to be inactive. The
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lack of any discernible difference in activity between ALTR3, ALTR4, and
A3(Xhol) indicates that the small sequence differences between these variants are
irrelevant. Although highly homologous in sequence, ALTR4 was almost twice as
active as 3.2-1. Therefore, LTR variants which contain similar sequence insertions
tend to behave approximately the same in vivo but smaller mutations can create
significant differences. In the case o f ALTR4 and 3.2-1, the additional adenine
residue and guanine to thymine transition, nucleotide positions -51 and -50
respectively, in ALTR4 create a more optimal AP-1 recognition sequence which
may be responsible for increasing its promoter strength relative to 3.2-1. It is also
possible that the thymine to cytosine transition at nucleotide -3 may influence
activity in an unidentified manner. When co-transfected with the EIAV Tat
expression plasmid pSV720 (Schiltz et al., 1992), the constructs showed different
stimulation of expression over basal levels. Prtt, PV44,3.2-3 and 3.2-5 showed
considerable stimulation, 17 to 25 fold, but ALTR3, ALTR4, A3(A7ioI), and 3.2-1
showed only a 5 to 10 fold stimulation making them approximately twice as active
as Prtt, PV44, 3.2-3 and 3.2-5 under transactivated conditions. In general, the
magnitude of transactivation was inversely proportional to the basal activity. This
effect causes the large differences in activity between LTR sequences under basal
conditions to become less distinctive when under transactivated conditions. A
similar effect has also been observed in studies of transactivation with the HIV-1
LTR (Antoni et al., 1994). Although less distinctive under transactivated
conditions, there were still significant differences in levels of activity between
different LTR variants. For example, 3.2-1 remains more than twice as active as
Prtt.
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Table 3. Variant LTR activity in FDD cell cultures.
CPM/uU B-Gal.
Construct

Basal

Transactivated

Fold Increase

pALTR3/CAT

1744 ± 428s

8178±457s

5

pALTR4/CAT

1921 ±240s

10050±817s

5

pA3(XhoI)/CAT

1658 ± 3 l8 s

8995 ± 673s

5

p3.2-l/CAT

1105 ±264s

11293 ±792s

10

pPrtt/CAT

242 ±31

5406 ±227

22

pPV44/CAT

343 ± 78n

5800 ± 579n

17

p3.2-3/CAT

351 ±76n

6664 ± 559n

19

p3.2-5/CAT

215 ± 58n

5448 ± 580n

25

In FEA cell cultures, only the promoter activity of LTR variants 3.2-1, Prtt,
3.2-3, and 3.2-5 were measured (Table 4). Variants 3.2-1 and 3.2-5 were the most
active promoters in this cell type producing twice as much CAT activity as Prtt.
Although the average activity of 3.2-3 was higher than that of Prtt, it did not behave
significantly different. The only sequence motif common to these three variants
that is not found in Prtt is the duplicated PU. 1 motif. Based on this comparison, it
seems likely that the PU.l motif, or an overlapping one, is being recognized by a
transcription factor expressed in FEA cells. The second PU.l site duplication
found in 3.2-5 may be inactive either due to sequence differences or due to its
location further upstream from the TATA box. One of the most striking differences
between the results obtained in FEA cells and results obtained in FDD cells is the
magnitude of transactivation. Co-transfection with pSV720 resulted in as much as
a 90 fold increase in activity in FEA cells as apposed to the maximum increase of
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only 25 fold seen in FDD. Without the quantitation of cellular Tat levels, it is
difficult to discern whether this effect represents a difference in the mechanism of
transactivation or whether it is an experimental artifact caused by the expression
levels of EIAV Tat being different between the two cell lines. Similar to what was
seen in FDD cells, the magnitude of transactivation was inversely proportional to
the level of basal activity.

Table 4. Variant LTR activity in FEA cell cultures.
CPM/uU B-eal
Construct

Basal

Transactivated

Fold Increase

p3.2-1/CAT

270 ± 35s

I1489±1919n

55

pPrtt/CAT

127 ±29

14789 ±2427

90

p3.2-3/CAT

223 ± 38n

15012 ±3459n

67

p3.2-5/CAT

304 ± 3 Is

14390 ±2564n

47

In Cf2Th cells, LTR variants 3.2-1 and Prtt exhibited the strongest promoter
activities showing more than twice the activity of 3.2-3 which was the weakest
promoter in this cell type (Table 5). Variants ALTR3, ALTR4, A3(A7ioI), and
PV44 were not used in this study. Based on sequence homology, the most likely
motif responsible for the increased activity produced by 3.2-1 and Prtt is a PEA2
recognition site. There are two such possible sites in both Prtt and 3.2-1 while 3.23 and 3.2-5 have only one. The second site in the latter variants being interrupted
by sequence insertions. Although it demonstrates lower activity, p3.2-5 does not
differ significantly from Prtt. Variant 3.2-5 might be forming a transcription factor
complex different from both Prtt and 3.2-3 but what this difference might be is
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unknown. Although the magnitude of transactivation in Cf2Th cells was not as
pronounced as in FEA cells, it still tended to be larger than the magnitude of
transactivation in FDD cells. The maximum increase in activity in Cf2Th cells was
38 fold whereas it was only 25 fold in FDD cells. As discussed previously, without
a quantitation of cellular Tat levels it is impossible to conclude whether this result
represents a difference in the mechanism of transactivation or is merely the result of
more Tat being expressed in Cf2Th cells relative to FDD cells.

Table 5. Variant LTR activity in Cf2Th cell cultures.
CPM/uU B-eal
Construct

Basal

Transactivated

Fold Increase

p3.2-l/CAT

284 ± 39n

6366±630n

22

pPrtt/CAT

236 ±53

4985 ±572

21

p3.2-3/CAT

112 ± 13s

4263±509n

38

p3.2-5/CAT

160±20n

4738±516n

30

In combination, these results indicate that LTR variants behave differently
in a cell line dependent manner. Thus LTR variation could strongly influence the
adaptation of a virus quasi-species to a particular cell line in vitro and, by analogy,
influence cellular or tissue tropism in vivo. Based on the results obtained from
FDD cell cultures, which showed dramatic differences in activity levels under basal
conditions, it can also be speculated that LTR variation could influence the
virulence of a virus sub-type by increasing or decreasing its replication rate. The
identities of the transcription factors that actually interact with the LTR variants in
these cell types remain to be determined conclusively but some likely possibilities
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have been discussed based upon previous studies, sequence analysis, and basal
promoter strengths. Although the differences in promoter strength between variants
became less pronounced under transactivated conditions, they often remained
significant. The magnitude o f transactivation was also dependent upon cell type
but it is difficult to conclude whether this represented a difference in mechanism or
was an experimental artifact.
Deletion Analysis of the LTR
Reporter constructs containing deletions within the U3 region of Prtt,
pD(Alul/Hincll)/CAT, PD(///«dIII///mcII)/CAT, and pD(//mdIIIA4M)/CAT were
created using existing restriction enzyme sites in order to localize regions
predominately responsible for transcriptional activity. Prtt is the most highly
characterized EIAV LTR. Previous deletion studies, performed in a variety of cell
lines, with this variant indicated that virtually all the active enhancer elements were
located proximal to the hypervariable region (Carvalho et al., 1993; Carvalho et al.,
1993; Dom et al., 1988; Sherman et al., 1989). In order to confirm these
observations, these three Prtt deletion mutants were transfected via the calcium
phosphate precipitation technique into FDD, FEA, and Cf2Th cells. Values
represent an average of three trials, normalized with P-galactosidase activity, with a
standard error and statistical significance as indicated. The deletion mutants are
missing either the hypervariable region and flanking sequences,
pD(Alul/Hincll)ICAT (nucleotides -48 to -117), the remainder of the U3 region,
pD(Hindlll/Alul)/CAT (nucleotides -118 to -210), or both regions,
pD(//mdIII///mcII)/CAT (nucleotides -48 to -210) (Fig. 5).
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-210
NF-icB
NF-kB
pALTR3/CAT:
TGTGGGGTTT TTATGAGGGG TTTTATAAAT GATTATAAGA
pPrtt/CAT:
pD(^/«I///mcII)/CAT:
pD(///ndIII//l/aI)/CAT: ---------------------------------------------------------------------------------------pD(//mdIII///mc[I)/CAT:----------------------------------------------------------------------------------------

-120
ALTR3/CAT:
GTAAAAGGAA AGTTGCTGAT GCTCTCATAA CCTTGCATAA
pPrtt/CAT:
A
T
pD(AluUHincUyCAT.
A
T
pD(//i/idIIIM M )/CA T:---------------------------------------------------------------------------------------pD(HmdllVHincU)/CAT:--------------------------------------------------------------------------------------------------------------130 '
PEA2
ALTR3/CAT:
CCCAAAGGAC TAGCTCATGT TGCTAGGCAA CTAAACCGCA
pPrtt/CAT:
pD(AluUHincll)/CAT:
-------------------------------------------------------------------------pD(///>jdIII//l/«I)/CAT: ----------------------------pD (tfw dIII////>7C lI)/C A T:----------------------------------------------------------------------------------------------------------

-90
PEA2
AP-1
PU.l
AP-1
ALTR3/CAT:
ATAACCGCAT TTGTGACGCG AGTTCCACAT TTGTGACGCA
pPrtt/CAT:---------------------------------------------- --------------------------------------------pD(AluVHincliyCAT:
---------------------------------------------------------------------------------------------------------------p D ( H i n d l l U A l u l ) / C A 7 : -------------------------------------------------------pD(HindlWHincll)/CAT:----------------------------------------------------------------------------------------------------------------50
PU.l
ALTR3/CAT:
TTTAACTTCC GTTTTTACA GTATATAAGT GCTTGTATTC
pPrtt/CAT:
G
pD(AluVHincll)/CAT:
—
pD(////idIIIA4/Ml)/CAT: G
pD(///«dIII////«cII)/C AT: —

ALTR3/CAT:

-JO
+J______________JAR_____________
TGACAATCGG GCACTCAGAT TCTGCGGTCT GAGTCCCTTC

ALTR3/CAT:

+31
TCTGCTGGGC TGAAAAGGCC TTTGTAATAA ATATAATTCT

ALTR3/CAT:

+71
CTACTCAGTC CCTGTCTCTA GTTTGTCTGT TCGAGATCCT AC

Figure 5. Alignment of Prtt LTR deletion mutants. The LTR regions of reporter
constructs ALTR3/CAT and Prtt/CAT are shown aligned with deletion constructs derived
from Prtt/CAT. Deletion constructs are missing the hypervariable region and flanking
sequences (pD^/wI/Z/mcIiyCAT), U3 sequences upstream of the hypervariable region
(pD(//mdIIIM/uI)/CAT), and removal of both regions (pD(MndIIU//mcII)/CAT).
Putative c/s-elements are also identified.
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In FDD cell cultures, deletion of sequences encompassing the hypervariable
region, as indicated by pD(AluVHindi. )/C AT, resulted in greater than a 10 fold
decrease in basal activity when compared to Prtt (Table 6). In addition, deletion of
the these sequences seemed to affect transactivation by EIAV Tat. When co
transfected with pSV720, this mutant showed less than a 4 fold stimulation making
it 78 fold less active than Prtt under transactivated conditions. Deletion of
upstream U3 sequences, as shown by pD(//mdIIIA4/wI)/CAT, exhibited a less
pronounced but significant, 2 to 3 fold, drop in basal activity while showing a 42
fold stimulation upon transactivation. Strangely, deletion of almost the entire U3
region, as shown by pD(///«dIII////«cII)/CAT, also resulted in a 10 fold decrease in
activity under basal conditions but the magnitude of transactivation was restored to
25 fold.

Table 6. Prtt deletion mutant activity in FDD cell cultures.
CPM/uU B-eal
Construct

Basal

Transactivated

Fold Increase

pPrtt/CAT

250 ± 17

6583 ±616

26

pD(Alul/Hincll)/CAT

23 ± 5s

84 ± 15s

4

pD(HindlIUAluI)/CAT

99 ± 10s

4169±494s

42

pD(HindIIVHinclI)/CAT

25 ± 2s

629±130s

25

The results obtained with pD(Alul/HincU)/CAT and pD(///«dIIIA4/«I)/CAT
indicate that in FDD cells, enhancer elements close to the hypervariable region
have the greatest effect on transcription rate, but enhancer element(s) further
upstream also exert a significant influence. The dramatic decrease in the magnitude
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of transactivation caused by deletion of the hypervariable region might have been
caused by the removal of a recognition element(s) recognized by a cellular factor(s)
that either directly interacts with Tat or is indirectly required for Tat function.
In FEA cells, none o f the deletion construct activities differed significantly
from Prtt under basal conditions. The deletion mutant pD(yfM///mcII)/CAT
exhibited only 35% less activity than Prtt (Table 7). Thus the hypervariable region
may exert far less influence on basal expression in FEA as opposed to FDD cells.
This deletion construct still contains an intact PU.l motif directly upstream of the
TATA box, however, and transient gene expression assays with full-length LTR
variants indicated that PU. 1 motifs were being recognized by a factor in FEA cells.
Therefore this PU.l motif may be responsible for maintaining the relatively high
basal transcription rate. Similar to what was observed in FDD cells, deletion of the
hypervariable region decreased the magnitude of transactivation from 54 fold, as
seen with pPrtt/CAT, to only 6 fold, as shown by pD(Alul/Hincll)/CAT. The
simplest explanation for this result would be that EIAV Tat indirectly requires a
DNA c/s-element in order to function efficiently but results obtained with
pD(///«dIII///wcII)/CAT contradict this theory. Removal of almost the entire U3
region, pD(/fmdIII///mcII)/CAT, dropped the basal activity only 29% compared to
Prtt and, similar to what was observed in FDD cells, this deletion did not seem to
affect the magnitude of transactivation, as a 26 fold induction in activity was seen
under transactivated conditions. Deletion of upstream U3 sequences,
pD(//mdIII/4/wI)/CAT, actually increased activity under basal conditions by 38%.
A previous study performed using FEA cell cultures also indicated a possible
negative regulatory element in this region (Dorn and Derse, 1988). This deletion
did not have any discernible effect on the magnitude of transactivation.
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Table 7. Prtt deletion mutant activity in FEA cell cultures.
CPM/uU B-gal
Construct

Basal

Transactivated

Fold Increase

pPrtt/CAT

173 ±30

9410 ±820

54

pD(Alul/HinclT)/CAT

ll2 ± 2 8 n

631 ± 233s

6

pD(tfmdIIIM/uI)/CAT

239±50n

7951 ± 1408n

33

pD(/7mdIII////ncII)/CAT

123 ±3 In

3153 ± 929s

26

Cf2Th cells transfected with pD(Alul/Hincll)/CAT yielded results similar to
those obtained in FEA cells (Table 8). None of the deletion constructs exhibited
behavior significantly different than that of Prtt. There was a 35% drop in activity
under basal conditions and a virtual elimination of induction by transactivation.
Deletion of upstream U3 sequences, pD(/fmdIIIM/«I)/CAT, also lowered basal
activity by 35% but did not affect transactivation as activity was induced 16 fold in
the presence of Tat. Deletion of both regions, pD(MrtdIII////«cII)/CAT, resulted in
only a 29% drop in basal activity, but unlike the behavior observed in FDD or FEA
cell cultures, the deletion also resulted in a loss of response to transactivation.

Table 8. Prtt deletion mutant activity in Cf2Th cell cultures
CPM/uU B-gal
Construct

Basal

Transactivated

Fold Increase

3453 ±570

19

pPrtt/CAT

181 ±24

pD(Alul/Hincll)/CAT

115±20n

152±9s

1

pD(//mdIII//4M)/CAT

118±23n

1937 ± 256s

16

pD(//mdIII///mcII)/CAT

129±56n

432 ± 54s

3
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The identity of the actual cw-element(s) involved in the behavior of the
three deletion mutants can only be speculated upon using previously published
data. The results obtained in these studies indicate that the transcription factor
complexes formed with the EIAV LTR are quite different between cell lines.
Deletion of U3 sequences encompassing the hypervariable region and flanking
sequences, illustrated by pD(AluUHincll)/CAT, had a profound impact on promoter
activity in FDD but not FEA or Cf2Th cells. Even deletion of virtually the entire
U3 region, as shown by pD(Hindlll/HmclT)/CAT, had no significant effect on basal
activity in FEA or Cf2Th cells. There are three feasible explanations for these
results. The intact PU.l motif in proximity to the TATA box may be sufficient to
maintain transcription at a relatively high rate. Studies with full-length LTR
variants, however, indicated that the PU.l motifs were only actively recognized in
FEA cells. It is also possible that the presence of the TATA box itself is sufficient
to maintain basal transcription in these cell lines and that upstream enhancer
elements influence transcription in only a minor way. The last possible explanation
is that unidentified enhancer elements in the R and U5 regions of the LTR are being
recognized by factors in these cell lines. Another interesting observation made
during these studies was that transactivation was abrogated in FDD, FEA, and
Cf2Th cell lines upon deletion of the hypervariable region and flanking sequences,
but upon deletion of the entire U3 region, induction of transcription by Tat was
restored in FDD and FEA but not in Cf2Th cells. Using horse PBMC cultures,
Maury (1994) showed that the PU.l sites in the EIAV LTR were essential for
transactivation but had little affect on basal activity. She also demonstrated that
sequences 5' to the PU.l core motif were required for efficient recognition of this
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motif by cellular factors. Therefore, it is possible that FEA and FDD cells simply
require a recognition element in proximity to the TATA box for transactivation. As
already discussed, an intact PU.l element is present in all three deletion mutants,
however, it is only two base pairs downstream of the Hincll site used in the
construction of the deletion mutants. Deletion of sequences between the Alul and
Hincll sites and their subsequent blunt-end ligation, as described for the creation of
pD(^/«I///iwcII)/CAT, may have removed nucleotides 5' to the PU.l site essential
for its recognition. The ligation of the Hincll site to the synthetic Hindlll linker
sequence, as described in the creation of pD(7//rtdIII////ncII)/CAT, may restore the
essential nucleotides. The study by Maury (1994) also showed that Cf2Th cells did
not require the PU. 1 motifs for basal activity nor transactivation. Therefore, while
the PU. 1 motif may be sufficient to restore Tat responsiveness in FDD and FEA
cells, Cf2Th cells seem to require a different element altogether which would
explain why induction by EIAV Tat was not observed in C£2Th cells transfected
with pD(///ndIII//fmcII)/CAT as well as \iD(AlulIHincll)ICKY. To date, no studies
have shown that EIAV Tat recognizes any DNA cw-elements. Therefore, any
interaction an element would have with EIAV Tat must be an indirect one via the
cellular factor which recognizes it.
Analysis of ALTR3 Deletion Mutants
Oligonucleotide directed deletion mutagenesis was performed on ALTR3 to
further localize LTR c/s-elements active in FDD cell cultures and to study the
impact of mutations within the hypervariable region on promoter strength.
Deletion sizes varied depending on their location within the LTR. Large deletions
were created in regions where no transcription factor binding sites had previously
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pALTR3/Luc:
pD(-210/-185)/Luc:
pD(-181/-135)/Luc:

ALTR3/Luc:
pD(-l 8 1/-135)/Luc:
pD(-137/-l I8)/Luc:

ALTR3/Luc:
pD(-137/-l 18)/Luc:
pD(-l 17/-lOI)/Luc:
pD(-94/-87)/Luc:

ALTR3/Luc:
pD(-94/-87)/Luc
pD(-85/-80)/Luc
pD(-77/-61)/Luc
pD(-57/-43)/Luc

ALTR3/Luc:
pD(-57/-43)/Luc:
pD(-46/-31)/Luc:

ALTR3/Luc:
pD(l/26)/Luc:

ALTR3/Luc:
pD(32/90)/Luc:

ALTR3/Luc:
pD(32/90)/Luc:

-210
NF-kB
NF-kB
TGTGGGGTTT TTATGAGGGG TTTTATAAAT GATTATAAGA

-170
GTAAAAGGAA AGTTGCTGAT GCTCTCATAA CCTTGCATAA

-130
PEA2
CCCAAAGGAC TAGCTCATGT TGCTAGGCAA CTAAACCGCA

-90
PEA2
AP-1
PU.l
AP-1
ATAACCGCAT TTGTGACGCG AGTTCCACAT TTGTGACGCA

-50
PU.l
TTTAACTTCC GTTTTTACA GTATATAAGT GCTTGTATTC

-10
+]_____________ TAR_____________
TGACAATCGG GCACTCAGAT TCTGCGGTCT GAGTCCCTTC

+31
TCTGCTGGGC TGAAAAGGCC TTTGTAATAA ATATAATTCT

+71
CTACTCAGTC CCTGTCTCTA GTTTGTCTGT TCGAGATCCT AC

Figure 6. Alignment of ALTR3 deletion mutants. Deletion mutants were created
from the reporter construct ALTR3/Luc using a primer directed method as outline
in Materials and Methods. The LTR regions of the resulting deletion constructs are
shown aligned with the LTR region of pALTR3/Luc with deleted sequences as
indicated. Putative c/s-elements for the EIAV LTR are also shown.
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been identified while smaller deletions, of sequences in or near the hypervariable
region, were produced to remove putative motifs identified in previous studies or
by sequence analysis (Fig. 6). These deletion mutants were placed upstream of the
luc gene of the pGL2-Enhancer vector and the promoter strengths measured under
both basal and transactivating conditions. The pGL2-Enhancer vector and the luc
reporter gene were chosen for subsequent experiments because of increased
sensitivity which would help clarify small differences in activity between deletion
mutants. Constructs were transfected into FDD cell cultures via the calcium
phosphate precipitation technique. Values represent a mean of three trials,
normalized with (3-galactosidase activity, with a standard error and statistical
significance as indicated (Table 9).

Table 9. ALTR3 deletion mutant activity in FDD cell cultures.
CPM/nU B-Gal
Construct

Basal

Transactivated

Fold Increase

pD(-233/-l 85)/Luc

1572±391s

29698± 5517n

19

pD(-181/-135)/Luc

1830±499s

32805 ± 9095n

18

pD(-137/-118)/Luc

3180 ±475n

39209 ± 4500n

12

pD(-117/-101)/Luc

4400 ± I0 6 ln

47418 ±2677n

11

pD(-94/-87)/Luc

1406±405s

35819 ±7368n

25

pD(-85/-80)/Luc

2128±592s

38321 ±4792n

18

pD(-77/-61)/Luc

3968 ±1418n

42487 ± 5499n

11

pD(-57/-43)/Luc

1594±363s

23947 ±2148n

15

pD(-46/-31)/Luc

2003±237s

21254±1553s

11
table con’d
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pD(l/26)/Luc

4124±410n

4169 ± 969s

1

pD(32/90)/Luc

5222 ± 1250n

34076 ±4226n

7

pALTR3/Luc

6631 + 1461

43281 ±3164

7

The results showed that every deletion caused some loss of promoter
strength under basal conditions but that not all decreases were significant. There
was no indication of a negative regulatory element as seen in previous deletion
studies. While the activities of some deletion constructs, pD(-l 17/-101)/Luc,
pD(l/26)/Luc, and pD(32/90)/Luc, were only slightly lower, 21% to 38%, than that
of the full-length construct, pALTR3/Luc, the majority of the constructs
demonstrated more dramatic, approximately 50% to 75%, reductions in activity.
Sequences flanking the hypervariable region seemed to be very important, as shown
by pD(-94/-87)/Luc, pD(-85/-80)/Luc, pD(-57/-43)/Luc, and pD(-46/-31)/Luc,
while deletion of 17 base pairs within the large insertion unique to the FDDadapted LTR, as indicated by pD(-77/-61), resulted in only a 40% decrease in
promoter activity. Surprisingly, the removal of sequences near the beginning of the
U3 region, demonstrated by pD(-233/-185)/Luc and pD(-181/-l35)/Luc, also had a
large impact on basal transcription rates resulting in 76% and 72% drops in activity
respectively. Computer homology searches indicated that this area contains
imperfect sequence repeats which differ from an NF-kB consensus binding
sequence (GGGRHTYYHC) (Lenardo and Baltimore, 1989) by only one base pair.
Deletion of PU.l, pD(-46/-31)/Luc, or PU.l and AP-1, pD(-57/-43)/Luc, sites
immediately upstream of the TATA box resulted in 70% and 76% drops in activity
respectively. Therefore, the PU.l element is very important for basal transcription
levels. It is impossible to conclude whether the AP-1 site is inactive or whether it
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behaves synergistically with the adjacent PU.l site. Removal of the duplicate AP-1
and PU.l sites, pD(-77/-61)/Luc, had a less dramatic effect resulting in a 40%
decrease in activity. Deletion of one, pD(-85/-80)/Luc, or both, pD(-94/-87)/Luc,
PEA2 sites decreased activity 68% and 79% respectively indicating an important
role for these elements in the control of the LTR in FDD cells. Deletion of large
portions of the R region, pD(l/26)/Luc, had a modest impact on basal activity
resulting in a 38% decrease. It is possible this region contains a recognition
element but no other studies have indicated one in this region. Deletion of the
remainder of the R and U5 regions, pD(32/90), decreased activity by 21% this
difference was not significant.
None of the deletions within the U3 region affected the degree of
transactivation as significantly as the large deletion mutant, pD(^/wI///mcII)/CAT,
of the Prtt LTR. Under transactivating conditions, all deletion mutants showed
significant stimulation except pD(l/26)/Luc which deletes the putative EIAV
transactivation response element (TAR) (Derse et al., 1993). Deletion mutants that
demonstrated a dramatic loss of basal promoter activity, such as pD(-233/-185)/Luc
and pD(-94/-87)/Luc, showed considerable stimulation by EIAV Tat,
approximately 19 and 26 fold increases respectively. Mutants that demonstrated
basal promoter activity levels near that of the full length ALTR3, such as pD(-l 17/101)/Luc and pD(32/90)/Luc, were stimulated only 11 and 7 fold respectively. As
seen in the previous expression study with LTR variants, the degree o f stimulation
by transactivation tended to be inversely proportional to the level of basal activity.
This causes the significant variation in promoter activity between deletion mutants
under basal conditions to become less distinctive under transactivated conditions.
Only in the case of pD(-46/-31)/Luc, which deletes the PU. 1 motif closest to the
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TATA box and dramatically reduces basal activity, does this effect not seem to
apply as induction by Tat for this mutant was only 11 fold. It is possible that this
deletion may affect the mechanism of transactivation as discussed in the previous
study of Prtt deletion mutants.
These results indicate a large number of m-elements spread throughout the
U3 region that act in concert to control transcription from the EIAV LTR and
which is similar to results obtained from deletion studies o f the Bovine
immunodeficiency virus and Visna-maedi virus LTRs (Fong et al., 1995; Hess et
al.,. 1989). The most significant elements are clustered near the hypervariable
region and include the PU.l and PEA2 recognition sites although there appears to
be an important element(s) in the upstream regions of U3 as well. It is unlikely that
each deletion resulted in the loss of a recognition element despite the fact that they
all demonstrated less activity than the full-length LTR. Instead, this may indicate a
requirement for correct spacing between existing elements. For example, LEF
imparts a 110° turn in the HIV LTR which is believed to allow factors bound to
upstream regions to interact with those in proximity to the TATA box. This
mechanism requires correct spacing between the LEF recognition site and both
upstream and downstream elements (Jones and Peterlin, 1994). In the Mouse
mammary tumor virus LTR, exact spacing is required between glucocorticoid
response elements. The exact spacing allows the two elements to lay in proximity
to one another when the LTR is assembled with the nucleosome complex (WolfFe,
1994). It is interesting to note, that Carvalho and Derse (1993) identified an MDBP
element in the EIAV LTR. MDBP has subsequently been identified as a histone
HI homologue (Bruhat and Jost, 1995). Spacing may therefore also be important
between elements in the EIAV LTR upon assembly into chromatin
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Quantitation of Variant LTR Sequences in Infected Horse Tissues
As shown previously, variant LTR behavior is dependent upon cell type.
The LTR also contains a large number of putative regulatory c/s-elements that may
allow the virus to respond to a variety of different cellular environments. This
indicates that LTR variation may play a role in cellular adaptation or tropism in
vivo. Quantitation of two different types of variant LTR sequences in several horse
tissues was performed using the technique of competitive PCR. Total DNA from
liver, lymph node, kidney, and lung tissue of an experimentally infected horse was
obtained from Dr. Susan Payne. Primer P-l was designed to recognize and amplify
LTR variants homologous to 3.2-1 while primer P-3 was designed to recognize and
amplify LTR variants homologous to 3.2-3. In addition to either P-l or P-3 and
horse tissue DNA, each amplification reaction contained either purified 3.2-1 or
3.2-3 DNA at decreasing concentrations. Both external controls, 3.2-1 and 3.2-3,
contained an internal deletion allowing their amplification products to be separated
from the amplification products of the horse DNA by polyacrylamide gel
electrophoresis.
This study indicated that variant LTR sequences homologous to 3.2-3 were
by far the most prevalent in all tissues examined (Fig. 7). Amplification of variants
homologous to 3.2-1 could not be achieved in any tissue even upon extension of the
reaction to 50 cycles. Distribution of viral DNA was somewhat similar between
tissues, with liver and lymph node demonstrating a transition from control
amplification products to horse DNA amplification products between reactions
containing 3.0 and 0.3 pg external control and 150 ng tissue DNA. The transition
for kidney tissue occurred at 3.0 pg external control while lung tissue, obtained by
lung lavage, demonstrated less viral DNA with the transition occurring between
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Figure 7. Quantitation of LTR variants in infected horse tissue DNA. Competitive
PCR reactions were run with primers specific for variant LTR sequences
homologous to 3.2-1, as shown by P-l, or with primers specific for variant LTR
sequences homologous to 3.2-3, as shown by P-3. In addition to 150 ng of tissue
DNA, reactions contained purified plasmid DNA containing either 3.2-1 or 3.2-3,
each containing a small deletion, in decreasing amounts, from 300 pg to 0.03 pg.
Cl reactions contained genomic DNA isolated from FDD cell cultures infected
with virus derived from the molecular clone pSPEIAVAd3 in the case of P-l
reactions or from FDD cell cultures infected with virus derived from the molecular
clone pSPEIAV44 in the case of P-3 reactions. C2 reactions did not contain tissue
DNA. The tissues used were: (Panel A) liver, (Panel B) kidney. (Panel C) lymph
node, and (Panel D) lung (isolated by lung lavage).
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reactions containing 0.3 and 0.03 pg external control DNA. Assuming 6x10^ kb
per diploid genome, and 5.3 kb per plasmid control, the number of LTR sequences
per liver cell is between 2.4 and 24. Numerous studies have shown that EIAV
infects macrophages almost exclusively. Macrophages in the liver (Kupffer cells)
account for about 10% of the cells by number (Rice et al., 1989). Assuming a
100% infection rate and two LTR regions per provirus, the results indicate that each
liver macrophage contains between 12 and 120 copies of the EIAV pro viral
genome.
These experiments yielded some very unexpected results. It was very
surprising that LTR variants homologous in sequence to 3.2-1 could not be
amplified from any infected horse tissue even with extended cycles. It is not very
likely that this is the result of poor amplification as the primer P-l recognized and
amplified the control plasmid. An additional primer, different in sequence from
primer P-l but specific for 3.2-1, was also tested and failed to amplify any products
from tissue DNA. In these particular tissues therefore, sequences homologous to
3.2-1 were present in quantities so low, if they were present at all, they can be
considered irrelevant. Although this experiment was performed with tissue DNA
from a single animal that was euthanized during its first disease episode shortly
after infection, it can certainly be speculated that there is no strong selective
pressure for LTR variants between tissues and that LTR sequences homologous to
3.2-3 are sufficient to enable a pathogenic virus strain to cause acute disease. This
probably indicates that LTR variants similar to 3.2-3 are the most active promoters
in vivo and confer a selective advantage upon their own viral genotype. It remains
to be determined however, if LTR regions homologous to 3.2-3 are required for
pathogenicity. It is also not known if more divergent LTR sequences would appear
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if the host were allowed to live through multiple disease episodes. These
experiments also indicated a very high number of proviruses per macrophage based
upon data for liver tissue (the only tissue for which the percentage of macrophage
cells was available). Another study used hybridization techniques and calculated a
proviral copy number of between 6 and 60 per macrophage cell (Rice et al., 1989).
There are likely explanations for the two-fold discrepancy such as the inherent
inaccuracy of both experimental techniques and differences in the level of viremia
or percentage of cells infected between the subject horses. Previous studies using
immunofluorescence, and hybridization have shown that the liver and lymph node
are primary sites for EIAV replication. Kidney and lung tissue, while positive for
EIAV replication and antigen, were not previously shown to be primary sites of
replication (McGuire et al., 1971; Sellon et al., 1992). In this study however,
kidney tissue contained the highest proviral copy number of all. Once again, this
discrepancy may be due to the wide range of error inherent in the experiments
themselves or differences in the horse subjects. It may also be the result of
differences in the level of virus expression as the previous studies measured viral
mRNA and antigen production. It is possible that while a high percentage of
kidney macrophages are infected they may not be expressing the virus. This
explanation is supported by two studies which show that EIAV replication is
restricted to mature tissue macrophages and does not occur in circulating
monocytes although they do contain proviral DNA (Maury, 1994; Rice et al., 1989,
Sellon et al., 1992).
Progress of Infection in FDD Cell Cultures
To assess the impact of the LTR on replication capacity and
cytopathogenicity, ALTR3 was cloned into an infectious molecular clone of EIAV,
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pSPEIAV44. This was accomplished by creating anXhol site within ALTR3 as
well as within the 3' LTR of pSPEIAV44. The portion of ALTR3 between the Xhol
and Stul sites was subsequently used to replace the corresponding portion of the
cognate LTR of pSPEIAV44. Infection of FDD cell cultures by virus derived from
the resulting clone pSPEIAVAd3 as well as the original pSPEIAV44 and AFDD
virus strains were monitored by cell proliferation assays, measurement of reverse
transcriptase activity, Northern and Southern blot analysis, and
immunofluorescence.
Cell viability was determined daily for all three infections as well as
uninfected cultures by measuring the reduction of a tetrazolium compound into a
formazan product that was released into the cell culture media and quantitated.
This procedure measures the overall metabolic activity of the cell culture which is
directly proportional to the number of viable cells, assuming a similar rate of
growth. Absorbance measurements obtained during the initial days of infection
continually increased until the cultures reached confluency after which the
measurements tapered off to a low point around day 9 (Fig. 8). Measurements
obtained from uninfected cell cultures and those infected with the pSPEIAV44 and
pSPEIAVAd3 virus strains slowly rose from the low point on day 9 until the
maximum propagation time of FDD cell cultures was approached around day 19
when they dropped severely. Microscopic examination of the cell cultures infected
with the pSPEIAV44 and pSPEIAVAd3 virus strains gave no indication of any
cytopathogenic effects during the life-span of the cultures. Absorbance
measurements obtained from cell cultures infected with the cytopathogenic AFDD
strain reached a low point at day 13. Microscopic examination of the cell culture
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Figure 8: Cell culture viability for infected and mock-infected FDD cell cultures.
Assays were performed during the course of the experiment according to
procedures outlined in Materials and Methods.
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Figure 9. Visual appearance of FDD cell cultures. Both mock-infected (Panel A)
and AFDD infected (Panel B) FDD cell cultures were stained and photographed ten
days post-infection. Bar represents a length of 50 uM.
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during this period showed an extreme deterioration of the cell culture monolayer
and a dramatic reduction, greater than 6 fold by day 13, in viable cells (Fig. 9). As
the infection progressed, the monolayer was slowly regenerated by cells evidently
resistant to the cytopathic effects of the virus. Absorbence measurements from the
culture during this period steadily increased from day 13 to day 18 after which the
values dropped, as seen in all cell cultures, on day 19.
Based on these observations, it can be concluded that the AFDD LTR alone
does not confer the cytopathogenicity of the original AFDD strain upon a molecular
clone. Additional studies such as the measurement of reverse transcriptase
production, Northern and Southern blot analysis, and immunofluorescence, were
performed to determine if the replacement of the LTR affected replication kinetics
or viral phenotype in any way. The subsequent experiments also served to further
characterize the behavior of the cytopathogenic FDD-adapted virus strain.
Analysis of reverse transcriptase activity was performed by harvesting cell
culture supernatants every 24 hours and precipitating the virus with polyethylene
glycol. Solubilized viral pellets were mixed directly with the template
oligonucleotide and [^H]dTTP. Values represent incorporated CPM minus
background.
Daily measurement of reverse transcriptase activity in the cell culture media
showed similar profiles for both the pSPELAV44 and pSPEIAVAd3 strains. Both
strains show activity steadily increasing during the course of infection to a
maximum peak of activity on day 17 followed by a rapid decline in activity as the
maximum propagation time of FDD cell cultures is approached (Fig. 10).
However, even though the curve profiles are similar, cell cultures infected with
pSPEIAVAd3 consistently exhibited more reverse transcriptase activity than twice
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Figure 10. Reverse transcriptase production by infected FDD cell cultures.
Production of reverse transcriptase by FDD cell cultures, infected with
pSVEIAVAd3, pSVEIAV44, or AFDD virus strains, was monitored using the
procedures outlined in Materials and Methods.
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the activity as pSPEIAV44. FDD cell cultures infected with AFDD produced
cultures infected with pSPEIAV44. On day 17, pSPELAVAd3 showed almost a
peak of reverse transcriptase activity by day 14 after which activity steadily
decreased for the remainder of the infection. Although the activity profile of
AFDD was similar to the profiles demonstrated by the pSPELAV44 and
pSPEIAVAd3 virus strains, reverse transcriptase production by AFDD was
accelerated relative to the other virus strains in that its maximum peak of activity
occurred three days earlier in infection than the corresponding peaks of activity
demonstrated by the pSPELAV44 and pSPEIAVAd3 virus strains. In addition,
AFDD never produced the same levels of activity as the virus strains pSPELAV44
and pSPEIAVAd3. Its maximum level of activity during the course of infection,
day 14, was 3 fold less than the maximum level achieved by pSPELAVAd3 on day
17.
Assuming reverse transcriptase activity is directly proportional to virion
production and is an accurate measurement of replication capacity, these results
indicate that the FDD-adapted virus LTR increased the replication capacity of the
molecular clone. The difference in activity produced by cultures infected with
pSPEIAVAd3 and those infected with pSPEIAV44 was not due to unequal levels
of proviral DNA as indicated by subsequent Southern blotting. The study also
showed that the cytopathogenic effects of AFDD are relatively independent of its
replication capacity. Therefore, the cytopathogenicity of the AFDD strain is not
caused by the excessive production and secretion of virions. The actual pattern of
reverse transcriptase production by AFDD infected cultures is difficult to reconcile
with the previous study on cell culture viability. Activity produced by AFDD
began to drop several days in advance of the severe monolayer deterioration
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witnessed by day 13. It is possible that the visible signs of monolayer deterioration
may lag behind widespread host cell death by a considerable amount of time.
Although it is impossible to determine from these studies the degree or even the
actual existence of this lag time, a large time difference between visual
cytopathogenic effects and the actual onset of cell death may help explain reverse
transcriptase production, or the lack thereof, by AFDD infected cell cultures late in
infection. It is possible that the second peak of activity produced between days 13
and 15 by AFDD infected cultures preceded yet another round of monolayer
deterioration that was simply never witnessed due to the life-span of the culture
being reached at day 19.
Analysis of viral mRNA during the course of the infections by Northern
blot indicated little difference between the pSPEIAV44 or pSPEIAVAd3 strains at
the mRNA level. Northern blot analysis of total RNA from infected cell cultures
showed three characteristic EIAV specific mRNA bands: an 8.2 kb band, the
unspliced mRNA which produces the gag and pol gene products as well as serving
as virion RNA; a 3.2 kb band, a singly-spliced mRNA species that produces the env
as well as the S2 open reading frame gene products and EIAV Tat; and a 1.5 kb
band, consisting of multiply-spliced mRNA species that produce the EIAV Tat,
Rev, and the non-characterized Ttm proteins (Derse et al., 1993; Rasty et al., 1990).
Upon poIy-A RNA selection, the 1.5 kb viral mRNA species decreased to virtually
undetectable levels (Fig. 11). Both the pSPEIAV44 and pSPEIAVAd3 infections
show a low abundance of viral mRNA early in the infection, detectable only by day
6, which increases during infection, illustrated by day 12, and then rapidly
decreases as the host cell culture reaches the end of its life-span, shown by day 18.
Both infections show a more intense 3.2 kb band relative to the 8.2 kb band. The
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Figure 11. Analysis of viral mRNA by Northern blot hybridization. Poly-ARNA
isolation from infected FDD cell cultures and Northern blot hybridization was
performed as outline in Materials and Methods. Location and identification of
molecular weight size markers is indicated at the left as is a mock-infected control
(lane B). (Panel A) Analysis of viral mRNA produced by cultures infected with
pSPEIAVAd3 on day 6 (lane 1), day 12 (lane 2) and day 18 (lane 3) post-infection.
(Panel B) Analysis of viral mRNA produced by cultures infected with pSPEIAV44
on day 6 (lane 4), day 12 (lane 5) and day 18 (lane 6) post-infection. (Panel C)
Analysis of viral mRNA produced by cultures infected with AFDD on day 6 (lane
7), day 12 (lane 8) and day 18 (lane 9) post-infection. Markers at right indicate the
approximate sizes of the three viral mRNA species detected.
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AFDD infected cell cultures show a dramatic increase, at least 10 fold, in the
overall amount of viral mRNA relative to the pSPEIAV44 and pSPEIAVAd3
infections. This strain produced a large amount of viral mRNA detectable by day
6, which then slightly decreased during the course of infection, as indicated by day
12 and day 18. Both the 3.2 kb and 8.2 kb bands showed a similar intensity.
Based upon these results, it can be concluded that despite an increased basal
transcription activity, the AFDD LTR had no detectable influence on viral mRNA
production by the molecular clone and that neither pSPEIAVAd3 nor pSPEIAV44
produced the large amount of viral mRNA demonstrated by cultures infected with
AFDD. In actuality, the technique of Northern blotting is prone to a great deal of
variation between trials and between individual samples. This inherent inaccuracy
of the technique coupled with the fact that these blots are based upon only one trial
makes the strict quantitative interpretation of these results questionable. Although
there is no doubt that AFDD produces far more viral mRNA than pSPEIAVAd3
and pSPEIAV44, it cannot be concluded with any reasonable certainty whether
there are small quantitative differences in viral mRNA levels produced by
pSPEIAVAd3 and pSPEIAV44.
Southern blotting was performed in order to monitor the relative levels of
proviral DNA present in infected cell cultures. Total cellar DNA was isolated and
purified from infected cell cultures and digested to completion with Stul. This
cleaves EIAV proviral DNA once in each LTR. Upon complete digestion, a
roughly 8.2 kb EIAV proviral DNA band should be produced. Examination of the
results obtained from this experiment showed that cultures infected with
pSPEIAVAd3 and pSPELAV44 contained approximately the same amount of
proviral DNA, relative to one another, throughout the course of infection (Fig. 12).
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Figure 12. Analysis of cellular DNA by Southern blot hybridization. Total
cellular DNA was isolated from infected FDD cell cultures, digested to completion
with Stui, and subjected to Southern blot analysis according to the procedures
outlined in Materials and Methods. The location and size of molecular weight
markers are indicated at the left as is a mock-infected control (lane B). (Panel A)
Cellular DNA isolated from cultures infected with pSPEIAVAd3 on day 6 (lane 1),
day 12 (lane 2), and day 18 (lane 3) post-infection. (Panel B) Cellular DNA
isolated from cultures infected with pSPEIAV44 on day 6 (lane 4), day 12 (lane 5),
and day 18 (lane 6) post-infection. (Panel C) Cellular DNA isolated from cultures
infected with AFDD on day 6 (lane 7), day 12 (lane 8), and day 18 (lane 9).
Marker at right indicates the approximate size of digested proviral DNA.
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Both cultures showed a somewhat weak, approximately 8.2 kb band by day 6 post
infection which gradually increased in intensity during the course of infection as
illustrated by results obtained on days 12 and 18. Cultures infected with AFDD
once again produced markedly different results, exhibiting a 8.2 kb band by day 6
which increased in intensity even more during the course of infection, as illustrated
by results from day 12, and then decreased slightly as the end of the culture life
span was approached at day 18.
Once again, it must be stated that precise quantitative interpretation of these
blots is questionable due to their own inherent imprecision and the lack of multiple
trials. Clearly, AFDD infected cultures contained considerably more proviral DNA
than cultures infected with pSPEIAVAd3 and pSPEIAV44. This finding throws
considerable doubt upon the theory that the accelerated cytopathogenicity exhibited
by AFDD is caused by the production of increased amounts of viral mRNA. Taken
together, the results obtained from the Northern and Southern blots seem to indicate
that AFDD proviral DNA produces amounts of mRNA comparable to that
produced by pSPEIAVAd3 or pSPEIAV44 but that AFDD infections result in
considerably more proviral DNA. Cytopathogenic retrovirus strains that exhibit
increased amounts of proviral DNA have been extensively studied and this
phenotype is believed to result from the loss of host cell immunity to super
infection by the virus strain. Changes in the virus-host cell recognition process can
result in the inability of the virus to down-regulate its own host cell receptor later
on in infection.
In order to determine if the increased amounts of proviral DNA and viral
mRNA produced by FDD cultures infected with AFDD were due to super-infection
or simply due to a larger percentage of host cells being infected,
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immunofluorescence studies were performed to determine the percentage of cells
expressing EIAV antigen within a culture. In brief, samples of cell cultures at
various stages post-infection were fixed on slides and incubated with a rabbit
polyclonal antiserum raised against a peptide corresponding to gp90, the surface
protein of EIAV. Subsequent incubation with a Fluorescein conjugated antiserum
against rabbit IgG and microscopic examination under both visible and blue light
allowed the determination of the percentage of cells containing gp90 which is a
strong indication that the cells are infected with EIAV (Appendix A).
Cultures infected with AFDD showed a high percentage, 25%, of
fluorescent cells as early as day 6 which increased during the infection to
approximately 40% on day 12 and 36% on day 18. Cultures infected with
pSPEIAVAd3 yielded no detectable fluorescence until day 12 when approximately
10% of the host cells expressed antigen. By day 18, this percentage had risen
sharply to 50%. Cultures infected with pSPEIAV44 gave similar results, not
demonstrating a strong amount of fluorescence until day 18 at which time 40% of
the host cells expressed antigen.
The large percentage of fluorescent cells detected in cultures infected with
AFDD is in agreement with the previous results obtained from Northern and
Southern blotting. These results indicate that, to some extent, increased amounts of
proviral DNA and viral mRNA detected in AFDD infected cultures, relative to
cultures infected with pSPEIAVAd3 and pSPEIAV44, was due to a higher
percentage of host cells being infected. This does not reconcile all results,
however. Whereas cultures infected with pSPELAVAd3 and pSPEIAV44 contained
a large percentage of fluorescent cells later in infection but Northern and Southern
blot analysis still indicated lower levels of proviral DNA and viral mRNA relative
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to cultures infected with AFDD. It must be noted, however, that samples harvested
on day 18 post-infection were used to represent the late stages of infection. By this
time, cell cultures were approaching the end of their life-span and both cell viability
and reverse transcriptase production were dropping.
Overall, these studies indicate that replacement of the LTR region of a
molecular clone, pSPEIAV44, by the corresponding region of AFDD failed to
confer cytopathogenicity upon the chimeric molecular clone, pSPEIAVAd3, but did
affect replication capacity, as shown by measurements of cell proliferation and
reverse transcriptase production. Detailed examination of the infections by these
and a variety of other techniques revealed several significant insights into the
behavior of the AFDD virus strain. Immunofluorescence studies as well as
Northern and Southern blot analysis agreed that the AFDD infects a large
percentage of the host cell culture which exhibit high levels of viral mRNA,
proviral DNA, and surface protein. Oddly, reverse transcriptase production by
these cultures was very low. It is possible that this represents a defect in proper
virion assembly and release. This defect may also result in the super-infection of
the host cell as Southern blot analysis indicates that even late in infection, when
cultures infected with pSPEIAVAd3 and pSPEIAV44 are releasing far more
reverse transcriptase activity and have infected comparable percentages of host
cells relative to cultures infected with AFDD, they do not exhibit comparable levels
of proviral DNA. Of course, the lack of induction seen at the viral mRNA and
proviral DNA level in cultures infected with pSPEIAVAd3 and pSPEIAV44 as
infections progressed is also noteworthy. The low levels of viral mRNA and DNA
indicated in the blots may be deceiving as samples were taken on day 18 post
infection when cell culture viability and reverse transcriptase production were
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dropping. It still seems unlikely however, that the levels would drop so
dramatically in such a short period of time.
Although far from conclusive, a possible description of the AFDD
replication cycle in FDD cell cultures can be constructed. Initial infection of the
cultures results in widespread infection and the rapid appearance of infectious
virions in the culture supernatant. As the levels of virions rises the majority of host
cells become super-infected resulting a decrease in intact virion production and host
cell death. Subsequently, cells that had escaped super-infection rapidly proliferate
and, once again, high levels of infectious virions begin to accumulate in the
supernatant resulting in a continuing cycle of virus production followed by host cell
super-infection and death.
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CHAPTER 4
SUMMARY AND CONCLUSIONS
Prior to this investigation, very little information was known about the
EIAV LTR and how transcription of the EIAV genome was regulated. Preliminary
studies had shown a high degree of LTR sequence variation between virus isolates
obtained from sequential disease episodes of an infected pony (Payne et al., 1987).
Comparison of the variant LTR isolates indicated that the sequence variation was
primarily located in a specific region approximately 60 base pairs upstream of the
TATA box. This region of the LTR, later dubbed the hypervariable region, was
prone to sequence insertions or duplications. Deletion studies performed in FEA
cell cultures showed that c/s-elements in proximity to the hypervariable region had
a dramatic impact on basal transcription (Dorn and Derse, 1988). Examined
together, these experiments indicated that elements critical for the assembly of the
basal transcription complex might be duplicated or changed in certain LTR
variants. It was further postulated, that LTR sequence variation may increase the
replication capacity of the virus influencing its pathology or allow the virus to adapt
to new cellular environments thereby influencing cellular adaptation or tropism.
Macrophages are a very heterogeneous cell type varying considerably in phenotype
between different locations in vivo (Weinberg and Athens, 1993). These
microscopic and antigenic differences must reflect differences at the molecular
level. LTR heterogeneity may allow the virus to infect the many different sub
populations of macrophages resulting in a more extensive infection of the host and
the high level of viremia required to cause acute disease. In the absence of a
pathogenic molecular clone, experiments designed to test these theories were
performed primarily in vitro.
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Sequence comparison between the highly characterized Prtt LTR sequence
and LTR variants isolated from diverse sources such as an infected pony, a tissue
culture-adapted strain of EIAV, and an infectious EIAV molecular clone, indicated
a number of sequence differences that could affect promoter strength. The most
significant differences occurred in the hypervariable region of the EIAV LTR and
resulted in imperfect duplication of the putative AP-1 and PU.l or interruption of
the PEA2 transcription factor motifs identified within Prtt (Carvalho and Derse,
1993a; Carvalho and Derse, 1993b). Variant LTR sequences from a tissue cultureadapted strain, ALTR3 and ALTR4, as well as one variant from an infected pony,
3.2-1, contained duplications of the putative PU.l and AP-l sites while retaining
both PEA2 sites. The cognate LTR of an infectious molecular clone, PV44, and an
additional horse isolate, 3.2-3, contained a duplication of the PU.l element but this
mutation interrupted one PEA2 motif. The final horse isolate, 3.2-5, contained two
additional putative PU.l motifs and possibly an additional AP-1 site as well.
Similar to the two previous LTR variants discussed, it contained an insertion which
interrupted the PEA2 motif. Based on this analysis, most LTR variants can be
placed into two general classes based upon sequence homology which differ
significantly in the transcription factor elements they contain.
Transient gene expression studies performed in FDD cell cultures using
these same LTR variants indicated significant disparities between basal promoter
activities overall but similar activity levels between variants belonging to the same
family. Variants ALTR3, ALTR4 and 3.2-1 all showed dramatically higher levels
of activity than Prtt, PV44,3.2-3, and 3.2-4. This indicates that AP-l and PEA2
binding motifs may be very important for LTR promoter strength in FDD cell
cultures. These differences became less pronounced when cells were co-transfected
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with an EIAV Tat expression plasmid but were still significant. Deletion mutants
created from Prtt, pD(^/uI////wcII)/CAT, and pD(//mdIH/<4/Ml)/CAT, which remove
the hypervariable region and U3 sequences upstream of the hypervariable region
respectively, indicated that elements in proximity to the hypervariable region as
well as in the upstream regions of the U3 were important for basal transcription.
Complete removal of the hypervariable region also decreased the magnitude of
transactivation. Similar assays were performed in FEA cell cultures but with only
the three horse isolates, Prtt, and the Prtt deletion mutants. The three horse isolates
were all more active promoters than Prtt but the differences in the basal levels of
activity, while significant, were not as dramatic as in FDD cell cultures. These
results implicate the PU.l site in LTR behavior in FEA cells. Under transactivating
conditions the differences in activity between variants became insignificant.
Deletion of the hypervariable region had far less an impact on basal transcription
than that seen in FDD cell cultures and removal of upstream U3 sequences actually
increased activity indicating the presence of a possible negative regulatory element.
Similar to the effect in FDD cells, removal of the hypervariable region decreased
the magnitude of transactivation. In Cf2Th cells, Prtt and 3.2-1 were the most
active promoters under basal conditions although the differences in activity levels
between these two variants and the remaining two were not as dramatic as seen in
FDD cell cultures. Under transactivating conditions, no variants maintained a
significantly higher activity. These results implicate the PEA2 sites in regulating
the LTR in Cf2Th cells. Deletion of both the hypervariable region and upstream
U3 sequences had only a moderate impact on basal transcription while deletion of
the hypervariable region abrogated transactivation completely.
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In conclusion, LTR variants behave differently depending upon cell type.
Therefore, LTR variation may play a role in tissue adaptation or tropism. Although
highly speculative, c/s-elements important in controlling basal transcription from
the LTR were putatively identified, and the requirement of a c/s-element, in
proximity to the TATA box, for efficient transactivation was demonstrated. It is
impossible to discern whether the cell dependent behavior of the LTR variants
reflects differences in the tissue sources or differences in species origin of these cell
lines. FEA and Cf2Th cell lines were chosen on the basis of their ability to support
replication of EIAV, their use in previous studies, and the unavailability of nondermal equine cell lines. Because o f their non-equid origins, additional studies in
these cell lines could not be justified despite the interesting observations made.
Peripheral blood macrophages could be obtained but not in large quantities,
required extensive purification, and were difficult to maintain. Although attempted,
transient transfection with reporter plasmids could never be achieved
Subsequently, the remaining experiments were all performed FDD cell cultures.
To further localize the c/s-elements within the EIAV LTR active in FDD
cell cultures, a more extensive deletion analysis was performed using the AFDD
LTR as a template. These deletion mutants revealed that sequences proximal to the
hypervariable region, which includes the AP-1, PU.l, and PEA2 motifs originally
identified within the prototype LTR, were highly important for basal transcription.
Deletion of the additional AP-1 and PU.l sites created by the sequence insertion
had only a moderate effect on basal transcription indicating that other sequence
variations contribute to the increased promoter strength of the AFDD LTR.
Deletions within the first 100 base pairs of the U3 region also had a dramatic
impact on basal promoter strength. No specific c/s-elements within this area of the
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EIAV LTR have previously been identified nor did previous deletion studies
indicate that this area had as great an effect on basal transcription as seen here
(Carvalho and Derse, 1993a; Carvalho et al., 1993). None of the deletions had as
dramatic an impact on the magnitude of transactivation as did the Prtt deletion
mutant pD(^/wI////«cII)/CAT. This may indicate that a specific crs-element is not
required but that any active element in proximity to the TATA box is sufficient for
efficient transactivation to occur.
These studies indicate that in FDD cell cultures, the EIAV LTR may contain
two core enhancer units; one centered within the hypervariable region and proximal
to the TATA box, the other within the first 80 base pairs of the U3 region. The
presence of multiple enhancer elements may allow the LTR to respond to a wide
variety of cellular environments. Of course, none of the elements or the factors that
recognize them have been definitively identified here. More extensive studies, such
as DNase 1 protection and mobility shift assays, were not performed. While the
deletion mutant experiments were being conducted, extensive studies on the
transcription factor complexes formed with EIAV LTR variants were published
making the results presented here merely confirmatory. Any future studies would
require a repetition of these assays in a monocytic cell line or, preferably, in
primary horse macrophage cultures with an emphasis on identifying the unknown
upstream elements should they be active in a monocyte/macrophage cell type.
In order to implicate LTR variability in cellular adaptation in vivo,
competitive PCR was performed with tissue DNA isolated from an acutely infected
horse using primer pairs specific for two different types of LTR variants. These
assays indicated that liver, lymph node, and kidney tissue were all infected at
roughly equivalent levels with virus possessing an LTR homologous to horse
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isolate 3.2-3. Lung tissue, isolated by lung lavage, was infected at lower levels but
also contained LTR sequences homologous to 3.2-3. Sequences homologous to
3.2-1 could not be amplified even under extended conditions. In this case, LTR
heterogeneity was neither required for the onset of acute disease nor was it even
detected at significant levels. It would be interesting to use this system to analyze
LTR heterogeneity in an infected horse over a longer time period. The host in this
case was euthanized during the first acute disease episode and there may not have
been sufficient time allowed for LTR divergence to arise
Replication of the FDD-adapted strain, AFDD, of EIAV in FDD cell
cultures presents a unique system for studying the viral determinants of replication
capacity or cytopathogenicity. Both the env and LTR regions are likely candidates
to contain these determinants as sequence comparison of EIAV isolates indicate
that these regions are prone to a high degree of sequence variability and that both
these regions influence replication capacity or cytopathogenicity in other lentivirus
systems (Brown et al., 1988; Carpenter et al., 1991; Dewhurst et al., 1990; Englund
et al., 1991; Golub et al., 1990; Payne et al. 1987). In a recent study, Cook et al.
(1995) replaced a region of env, which codes for the surface protein gp90, of the
infectious molecular clone, pSPEIAV44, with the corresponding region from
AFDD proviral DNA. The chimeric clone produced did not show any
cytopathogenic effects when replicated in FDD cell cultures.
A similar result was obtained in this study in which the LTR region of
AFDD was placed into pSPEIAV44. The resulting molecular clone, pSPEIAVAd3,
did not display any discernible cytopathogenic effects when replicated in FDD cell
cultures although it did demonstrate a higher replication capacity than pSPEIAV44.
Assuming reverse transcriptase activity correlates directly with virus production,
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reverse transcriptase assays performed on infected cell culture supernatants
indicated that pSPEIAVAd3 produced approximately twice as much virus as
cultures infected with pSPEIAV44. Cultures infected with AFDD showed the least
amount of virus production of all, indicating that the cytopathic nature of AFDD is
relatively independent of its virion production. Strangely, Northern and Southern
blot analysis indicated enormous amounts of viral mRNA and DNA in AFDD
infected cell cultures and immunofluorescence studies indicated large amounts of
surface protein antigen as well. Therefore the AFDD strain seems capable of superinfecting the host culture and possesses a deficiency in virion maturation and
egress. Which of these characteristics results in its accelerated cytopathogenicity is
impossible to determine. Any future studies on this virus will have to confirm
these results and analyze, as of yet, untested regions of the genome.
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